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ABSTRACT 
Joshua K. Herr 
DESIGN AND CHARACTERIZATION OF A MICROFLUIDIC FLOW 
CYTOMETER 
(Under the direction of J. Michael Ramsey) 
 
The development and characterization of a microfluidic flow cytometer is 
described in this dissertation for rapid, inexpensive fluorescence and scatter based 
cellular enumeration for biomedical diagnostic and monitoring applications.  Microfluidic 
cytometry enables a portable, economical platform for performing point-of-care cellular 
assays that are impractical with large conventional flow cytometry systems.  Microchips 
were fabricated from glass using standard photolithography and wet chemical etching 
techniques.  These chips were used in conjunction with static optical and electronic 
components to construct a robust instrument capable of accepting disposable microchips.   
Flow cytometry measurements on-chip have demonstrated cellular analysis at 
rates greater than 2 kHz using vacuum driven flow, and positive pressure driven flow 
cytometry has been performed to measure cells at 12 kHz.  Measurement precision has 
been investigated using commercially available calibration beads, and results demonstrate 
that the precision of chip based cytometry measurements is close to that seen using 
conventional instrumentation.   
Cell discrimination based on immunophenotyping has been demonstrated in 
mixtures of cultured cells, peripheral blood mononuclear cells, and whole blood to 
iii 
 
demonstrate the applicability of this instrument for clinical cellular diagnostic and 
monitoring applications.  Comparison studies have been performed using conventional 
cytometry instrumentation to assess the accuracy of our microfluidic system for 
immunophenotyping applications.   
Efforts have also been made to incorporate erythrocyte lysis on-chip in order to 
rapidly analyze whole blood in an automated fashion.  Chemical erythrocyte lysis 
followed by leukocyte cytometry has been integrated on a single monolithic device to 
demonstrate the ability to accurately measure cell subtype ratios from a whole blood 
sample while reducing off-chip sample processing steps.  Further, applications in blood 
dosimetry are described to reveal potential advantages of performing rapid blood cell 
counts for therapeutic monitoring and bioterrorism applications using only a fingerstick 
of whole blood. 
  The technology described in this dissertation may be applied to numerous 
applications requiring the measurement of relative cell populations from biological fluids.  
Further development and optimization of this instrument has the potential to increase the 
accessibility of clinical cellular analyses in resource poor settings by providing rapid, 
low-volume, inexpensive clinical testing at the point-of-care. 
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CHAPTER 1:  
FOUNDATIONS FOR FLOW CYTOMETRY BASED ON MICROFLUIDIC 
TECHNOLOGY 
 
1.1  Introduction  
Efforts to develop and commercialize miniaturized instrumentation for medical 
diagnostics have steadily increased over the past decade.  The aim is to produce devices 
that have similar performance features (sensitivity, accuracy, and reproducibility) as their 
full-scale laboratory counterparts but, in addition to providing rapid results, are more 
economical and robust.  The efforts are driven in part by trends toward personalized 
medicine where timely results are desired at the point of care for disease state or 
therapeutic regime monitoring.  Small, relatively inexpensive devices that may be used 
outside standard laboratory settings also have the potential to increase diagnostic and 
screening capabilities in rural and underdeveloped areas, greatly enhancing healthcare in 
those regions.  Furthermore, if rapid, inexpensive assays were available as alternatives to 
expensive screening methods they would be more widely employed, leading perhaps to 
more favorable medical outcomes.  
Accessibly priced personal assay kits that test for pregnancy, fertility, blood 
glucose, HIV, illicit drugs, and other disorders have been readily adopted and 
 
 
incorporated into standard practice throughout the world.  Point-of-care devices for 
simple blood chemistry testing and immunoassays have also been commercialized.1,2  
Similar devices for diagnosis and monitoring of more complex diseases such as 
autoimmune disorders and specific cancers are needed.  Assays for these diseases 
typically require the measurement of multiple parameters to obtain useful clinical 
information3 and consequently are more challenging to develop as point-of-care tests.  
Trained pathologists commonly perform these complex assays, but there are a few 
examples of simple, inexpensive, multi-parameter assays for the diagnosis and 
monitoring of disease states that can be performed easily by nonprofessionals.  Continued 
focus on the development of these assays will escalate the drive towards personalized 
medicine and greatly improve accessibility to these types of medical tests in resource-
limited regions.   
One of the first steps in the development of a point-of-care, multi-parameter 
diagnostic device is to establish the type of sample that will be tested and the analytes 
within the sample that will be detected.  Next, the signal transduction and detection 
mechanisms need to be defined.  To develop an automated device, sample processing 
steps such as dilution, rinsing, or separation may be required.  The materials necessary to 
fabricate the device must be selected based on cost, durability, sample compatibility, and 
constraints imposed by the detector.  The device needs to be designed to minimize its 
overall dimensions to reduce costs and enhance portability.  It should accommodate 
minimum sample volumes required for accurate analysis in consideration of the patient 
supplying the biological sample and discomfort resulting from invasive sampling 
2 
 
techniques.  Depending on the detector chosen for the assay, analog to digital signal 
conversion may be necessary, as well as appropriate software to process acquired data. 
Following the design and fabrication of the device, initial testing and 
characterization are necessary.  Biological samples derived from animal models or 
willing donors must be tested repeatedly and results compared to conventional screening 
assays.  The device should function as well as current technology but preferably with 
superior performance (higher sensitivity, lower cost per assay, greater speed, increased 
portability). Finally, if the device will be commercialized as a medical diagnostic tool, it 
must pass through a stringent regulatory approval process to ensure accuracy and 
safety.4,5  
The development (design, fabrication, initial characterization and testing) of an 
inexpensive multifunctional microfluidic device for rapid clinical diagnosis and disease 
state monitoring is described in this dissertation. Whole human blood was chosen as the 
sample since many disorders can be detected or monitored through blood analysis.  Intact 
white blood cells are of specific interest due to their diagnostic significance in 
autoimmune disorders,6-9 HIV,10,11 and hematologic cancers.12-14  Fluorescence from dye-
labeled antibody probes bound to cells and laser light scattering were used to detect cells 
in a microfluidic flow cytometer.  Microfluidic chips were fabricated from glass, which is 
relatively robust and amenable to optical based detection.  Since whole human blood is a 
very complex fluid, efforts were taken to reduce its complexity and enable selective 
analysis of white blood cells without significant interference from the other components.  
Contrived cultured cell mixtures, human blood, and murine blood samples were analyzed 
on-chip to simulate diagnostic assays typically performed on patient samples.  Results 
3 
 
from the microfluidic system were compared to those obtained on conventional 
instrumentation in order to assess the accuracy of the assays performed.   
The remainder of this chapter will provide a background review of the 
fundamental concepts in microfluidics and flow cytometry, as well as a review of cell 
based microfluidic applications to date.  In addition, this chapter will attempt to 
substantiate the need for an automated, portable microfluidic cytometry system for blood 
cell analysis.  The following chapter will discuss the design and fabrication of the 
microfluidic device, and the construction of the optical detection setup.  Chapter 3 will 
describe initial characterization experiments performed using the microfluidic device to 
assess the critical design properties and ultimate limitations of the device.  Chapter 4 will 
discuss the results from immunophenotypic analysis of cells from cell mixtures.  Finally, 
chapters 5-7 will cover the investigation of multiple biological applications using the 
microfluidic flow cytometer. 
 
1.2  Microfluidics Background  
 The origin of microfluidics can be linked to advancements in the microelectronics 
industry since many fabrication processes were borrowed or adapted to develop the 
technology.  Since the invention of the transistor in 1947 at Bell Laboratories,15 and the 
continued development of new integrated circuit technologies, the capabilities of 
electronic circuit manufacturing have continued to advance.  Consequently, efforts have 
focused on reducing the size of integrated circuits to develop small, powerful electronic 
devices primarily for the manipulation of encoded information, i.e., information 
4 
 
technology.  The result of these efforts is the vast microelectronics industry in existence 
today. 
Some of the techniques commonly employed for silicon-based circuit fabrication 
in the microelectronics industry have been adapted to develop advanced microfabricated 
chemical and biochemical sensors.  The intrinsic reproducibility of these techniques 
makes them ideal for the fabrication of microfluidic devices intended for 
commercialization.  Additionally, the spatial resolution afforded by these processes, 
which were perfected for producing small electronic chips, allows for the accurate 
fabrication of very small sensors.  The first example of a microfabricated chemical 
measurement device was a hybridized gas chromatograph where the separation column 
and thermal detector were machined on Si wafers.16  Further developments by Manz et al. 
and others were critical in advancing chemical separation-based microsystems by 
demonstrating the increased separation performance achievable by decreasing separation 
column dimensions.17-21  The field has since grown significantly to include a variety of 
separation techniques, chemical synthesis procedures, biological assays, and cell based 
assays.22-27  Additionally, microfluidic pumps, valves, detectors, and sensors have been 
developed for these systems.23,24,28-33   
Recent trends in the development of microfluidic devices have focused on 
integrating functional elements to create “lab-on-a chip” or total analysis systems.34-40  
The efforts to incorporate entire experimental protocols on microfabricated devices are 
directed towards minimizing the cost per analysis, increasing overall sample throughput, 
and enabling fully automated operation.  Advanced synthetic procedures, 
multidimensional chemical separations, biomedical diagnostic assays, and chemical 
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sensors have all been developed and commercialized in some cases.23,24  Parallel 
processing has also been demonstrated to increase analysis throughput.41 
Microfluidic devices have been fabricated from quartz,42 glass,43-48 and many 
polymeric materials.33,49-54  More complex multilayer devices have been produced using 
primarily soft lithography.30,31,33  A combination of photolithography, wet chemical 
etching and bonding techniques are typically used to fabricate devices from glass.19   
Starting with a patterned photomask, photolithography is commonly employed to pattern 
specific designs on substrates for microfluidic devices.  This procedure typically utilizes 
a thin layer of photoresist material spun on to the substrate surface that changes its 
chemical properties when exposed to radiation—typically ultraviolet light—to leave a 
pattern on the substrate after chemically developing and washing away exposed 
photoresist.  For devices fabricated from glass or quartz, a buffered solution of 
hydrofluoric acid is typically used to chemically etch the photolithographically patterned 
substrates to make channels.  Chemical etching of glass or quartz is an isotropic process, 
removing material uniformly in all directions, thereby limiting the maximum achievable 
aspect ratio (depth/width).  Channels in etched substrates can be enclosed by thermally 
bonding a flat piece of glass or quartz on top of the etched material. Via holes are 
typically drilled through the substrate or coverplate to permit access to channels where 
necessary.   These holes are typically drilled using ultrasonic milling or powder blasting 
techniques.55 
 General advantages of performing chemical analysis on microfluidic systems 
include the ability to precisely control the movement of small volumes of fluid, low 
reagent consumption compared to conventional systems, and overall reduced size and 
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cost of instrumentation.45,56-59  Additionally, the ability to inexpensively fabricate these 
devices makes them disposable, which is especially important when considering 
analyzing potentially infectious clinical samples on-chip.57 
 
1.3  Microfluidics Theory 
To describe a fluid traveling through a microfluidic channel, one can assume that 
there is a conservation of mass.  In addition, when describing an incompressible fluid—
meaning that the fluid density (ρ) is constant—there is also conservation of volume. 
Therefore, the continuity equation can be written as follows to describe the situation 
where fluid flow velocities (v) are much smaller than the velocity of pressure waves in 
the fluid.60   
׏ · v ൌ 0                                                                                                                                         ሺ1.1ሻ 
ߩሾ߲௧v ൅ ሺv · ׏ሻvሿ ൌ  െ׏p ൅  η׏ଶv ൅  ρg ൅ ρୣ୪E                                                               ሺ1.2ሻ
p ଶv
ୣ୪
Additionally, the Navier-Stokes equation can be written as follows to describe the motion 
of an incompressible fluid.   
 
This expresses the conservation of momentum with relation to the viscous and body 
forces acting on the fluid at any arbitrary location in the flow field at any instant of 
time,55 where – ׏  describes the force per unit volume on a fluid due to pressure, η׏  
describes the force per unit volume due to viscous forces, ρg describes the force per unit 
volume due to gravitational forces, and ρ E describes the force per unit volume due to 
electrical forces.  The Navier-Stokes equation for the situation where Poiseuille flow 
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dominates fluid flow in a circular cross-section channel can be solved to determine the 
velocity vector field across the tube area.  The velocity distribution relationship is as 
follows. 
ݒ୶ሺݎሻ ൌ  
∆݌
4ηL
ሺܽ૛ െ ݎଶሻ                                                                                                             ሺ1.3ሻ 
Q ൌ  
ߨܽସ
8ηL
 
The velocity distribution can then be integrated across the tube area to give the equation 
describing the volumetric flow rate Q. 
∆݌                                                                                                                                 ሺ1.4ሻ  
Where ܽ is the channel radius, η is the solution viscosity, L is the channel length, and ∆݌ 
is the magnitude of the pressure drop.  This is just a single example of a reduced form of 
the Navier-Stokes relationship.  When performing computational fluid dynamics (CFD) 
simulations for prospective microfluidic device designs, it is the Navier-Stokes 
relationship that is solved for with specific conditions defined based on the materials, 
fluids, and forces involved. 
 
1.4  Flow Cytometry Background 
Flow cytometry is a technology that is used for the simultaneous measurement of 
many characteristics of individual cells as they flow in a solution through a beam of light.  
This technology has been used for over 50 years, and has advanced over that time to 
incorporate numerous capabilities and advanced functionalities for characterizing cell 
populations that were not possible in an automated fashion previously.  Before the 
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development of flow cytometry, cell samples were characterized manually using 
microscopy techniques.  This practice is still common today for specific applications 
where the trained eye of a pathologist is needed for accurate assessment.  However, the 
high-throughput and multiplexing capabilities of conventional flow cytometry make it the 
widespread choice for complex cell sample characterization.  The development of the 
Coulter Counter also set the foundation for modern cytometry.   
Wallace Coulter developed an instrument in 1956 that passed a flowing cell 
suspension through a small aperture while simultaneously measuring ionic conductance.61  
This principle worked on the basis that the electrical conductivity of cells is lower than 
that of a buffer solution, resulting in increased impedance across the aperture when 
containing a cell.  This instrument allowed for counting and sizing of mixed cell samples, 
including complex mixtures of cells such as whole blood.  This is done by correlating cell 
size with measured changes in impedance.  This development in conjunction with the 
need for more advanced, higher-throughput microscopy techniques led to the 
development of modern flow cytometry. 
Many basic examples, as early as the mid 1940’s through the early 1970’s, 
describe the detection and sorting of colloidal particles and cells.  The work of F.T. 
Gucker and colleagues was based on the photoelectronic detection of colloidal particles 
in a laminar sheath stream of air for the detection of anthrax spores and other biowarfare 
agents, and was built for the U.S. Army during World War II.62  Louis A. Kamentsky 
developed spectrophotometric flow cytometry instruments and the first cell sorting 
instrumentation at IBM in the early 1960’s.63-65  However, the fluorescence based 
cytometry instruments developed commercially by Partec in 1968 and development of 
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the Fluorescence Activated Cell Sorter (FACS) by Herzenberg at Stanford can be 
credited with the basic framework for modern flow cytometry and cell sorting 
technology.66,67  These instruments established the capability for cellular differentiation 
and separation based on cells stained with fluorescent antibodies.  Another major 
development leading to the advanced utility of flow cytometry was the discovery of 
methods to produce monoclonal antibodies and other molecular recognition elements for 
extracellular, intracellular, and nuclear molecular targeting.68  The availability of 
monoclonal antibodies developed for specific cell surface proteins allowed for the facile 
discrimination of distinct cell subsets, greatly increasing the significance of 
immunofluorescence based cellular characterization by flow cytometry.   
Since the 1970’s, many advancements have been made to help develop state-of-
the-art flow cytometry instrumentation.69  Fluidic, optical, hardware, and software 
improvements have all assisted the evolution of modern flow cytometry.  These 
improvements have allowed for higher precision measurements at faster analysis rates.  
Also, significantly more physiochemical information can be obtained on a per-cell basis 
using modern instrumentation due to the incorporation of multiple lasers, and the 
continued development of fluorescent dyes and tandem-dye conjugates providing 
fluorescent markers that span nearly the entire range of the visible spectrum.  Current 
state-of-the-art instrumentation makes use of 2 or 3 lasers, allowing for the simultaneous 
detection of 12-18 different cellular parameters at throughputs surpassing 90,000 cells per 
second.69 
Information obtained by flow cytometry can be classified into two categories; 
intrinsic structural characteristics and extrinsic properties.  Intrinsic properties such as 
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cell size and granularity can be obtained using forward and side elastic light scatter based 
detection, which is incorporated in most modern cytometry instrumentation.  These 
properties allow for the separation of cell subsets from complex mixtures without 
fluorescent tags.  Many extrinsic properties can also be measured with the addition of 
targeted labeling reagents such as monoclonal antibodies conjugated to fluorescent dyes.  
Structural information such as DNA and RNA content and base ratios can be measured 
using specific nucleic acid stains.  Additionally, immunofluorescence measurements can 
be used to determine the presence and abundance of both surface and intracellular 
receptors.  Some other functional measurements commonly determined are cytoplasmic 
calcium levels, DNA degradation/ apoptosis, and enzyme activity.69  
 
1.5  Flow Cytometry Instrumentation 
 A modern flow cytometer has three main components; a fluidic system for cell 
transport, an optical system for detection, and a signal processing unit.69  Precise 
coordination of all three elements is necessary for accurate, reproducible high-speed 
measurements.  The major fluidic component is a flow chamber (shown in Figure 1.1).  
The purpose of the flow chamber is to align the cells in solution into single file within a 
narrow stream.  Hydrodynamic focusing is used to align the cells by forcing another 
stream of fluid—known as the sheath fluid—to envelop the cell sample stream as it exits 
the nozzle tip.  The sheath and cell streams are forced into a narrow tube after they 
combine, causing the cross-sectional area of the inner cell stream to narrow.  The cells 
remain within the narrowed stream and are aligned in single file.  The extent to which the 
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cell stream is narrowed, and consequently the cell alignment, can be adjusted for specific 
applications by varying the ratio of pressures applied to the cell sample and sheath 
solutions.  Flow velocities for cell sample solutions can exceed 10 meters per second with 
applied pressures ranging from 10 – 100 psi.   
The purpose of hydrodynamically narrowing the cell stream is to ensure that all 
cells pass through a small optical detection volume in a single file.  The detection volume 
is ideally similar to the volume of the cell so as to limit background signal from the 
buffer solution and maximizing optical signals from the cell.  As cells flow through this 
region, they pass through one or more focused laser spots.  These lasers are used to 
induce both light scattering and fluorescence from the cells.  A schematic of a simple 
flow cytometry optical configuration is shown in Figure 1.2.  An incident laser beam is 
passed through 2 cylindrical lenses in order to shape the beam into an elliptical profile.  
This elliptically focused beam is aligned so that the long axis is orthogonal to the cell 
stream flow, providing more uniform illumination of cells, independent of small 
deviations in the cell stream position as compared to a circular beam profile.70  The 
focused laser beam is directed through the hydrodynamically focused cells in the flow 
chamber. 
  As cells pass through the focused laser beam, elastically scattered light and 
fluorescence are emitted from each cell or from dye molecules attached to the cell.  
Optical components are aligned around the flow chamber to collect these signals.  The 
scattered light is typically collected from two directions; at a small angle from the 
incident beam and at a 90º angle from the incident beam.  Small angle scatter—also 
called forward scatter or FSC—is collected at angles < 10º from the incident beam with a 
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photodiode detector.  A beam stop may be placed in line with the incident beam in front 
of the photodiode so that the scattered light can be detected without saturating the 
detector.  Fluorescence and 90º scattered light (known as side scatter – SSC) detectors are 
placed orthogonal to the incident beam and forward scatter detector.  Side scatter 
signatures are used to reveal differences in cell surface roughness and granularity.  As 
shown in 1.2, the fluorescence and side scatter signals are passed through a series of 
dichroic mirrors that direct the different signals to individual photomultiplier tubes 
(PMT’s).  This enables the spectral separation of multiple fluorescence signals from each 
cell.  The first PMT can be used to detect the side scatter signal, while the remaining 
detectors are for the detection of fluorescence from different dye molecules conjugated to 
specific types of antibodies.  In front of each detector is a band pass filter to reduce the 
detection of light other than from the specific dye fluorescence corresponding to that 
channel.   
The output signals from each detector are amplified by passing through a current 
to voltage amplifier.  The signals are digitized and then immediately analyzed to extract 
peak intensities or areas from detected events.  A defined channel (normally FSC) is used 
to trigger data acquisition from all other detectors when a cell is present.  The values 
obtained from the channels of interest are loaded into a user defined software interface 
where results can be plotted to monitor the cell solution characteristics in real time.  
When more than one laser is used, there are multiple interrogation spots.  As a result, the 
signals from each laser interrogation point must be synchronized to ensure that the 
correct signals from each cell are properly correlated. 
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1.6  Microfluidics for Cellular Applications 
The inherent advantages of microfluidic devices have led to numerous 
applications incorporating cells.  Channel features on the micron scale allow for facile 
manipulation and interrogation of cells.  Examples of microfluidic cellular applications 
range from miniaturized examples of bulk processes, to complex, integrated analyses of 
cells not possible using conventional instrumentation.71,72  While numerous cellular 
applications have been demonstrated on microfluidic devices, this introduction will focus 
on previous demonstrations and advancements of microfluidic flow cytometry. 
Previous reports on microfluidic flow cytometry devices has predominately 
focused on strategies for fluid manipulation, cell focusing, integrating optical 
components, or demonstration of applications.58,73  Fluid manipulation on microfluidic 
devices for flow cytometry applications has been most commonly demonstrated using 
off-chip pumping methods.44,48,52,74-81  However, there are some examples where pumping 
and valves have been integrated on-chip.48,54,82  For example, electrokinetic pumping has 
been employed for fluid manipulation and hydrodynamic focusing of cells on chip.45,83,84  
Additionally, dielectrophoresis has been used for fluid manipulation for on-chip 
cytometry applications.85  
Strategies for microfluidic cytometry have been demonstrated using narrow 
channels that force cells through a detection region without any hydrodynamic 
focusing.86-90  Issues with this strategy include the increased shear stress experienced by 
cells as they pass through the narrow channel, as well as the increased probability for 
channel clogging as compared to examples employing hydrodynamic focusing.  
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Numerous examples of hydrodynamic focusing in a single dimension (i.e. in only one 
plane) on-chip have been demonstrated.45,47,49,53,58,74,77,84,91-94  This focusing strategy is 
commonly employed due to a simple microchip design and ease of fabrication. One 
example is based on a simple cross-channel intersection first described by Jacobson et. 
al.83  While one-dimensional focusing is most common, issues with this strategy still exist 
including shear effects in the dimension not being focused, and variations in the location 
of cells as they pass by the detection region.  Two-dimensional hydrodynamic focusing 
strategies have also been developed for flow cytometry applications on-chip.51,52,95-99  
Although this focusing approach most closely resembles the focused sample stream 
profile obtained in conventional capillary based cytometry systems, fabrication of these 
devices can be complex and multiple layers of patterned material must be properly 
aligned and bonded in order to successfully obtain the desired hydrodynamic focusing 
effect. 
Efforts to integrate optical components into microfluidic cytometry devices have 
been demonstrated in order to reduce the amount of large-scale external components 
necessary for optical measurements.  Optical fibers or materials such as SU-8, PDMS, 
and other polymers have been incorporated on-chip to act as optical waveguides.48,88,92-
94,100  These waveguides are used to direct and focus the excitation light to the cells on-
chip.  Another approach has been to incorporate a low power dye laser on-chip with 
integrated waveguides and photodiodes for optical fluorescence measurements in 
fluids.101,102  Negative aspects to these integrated designs are the added complexity in 
fabrication and the increased cost associated with producing devices containing different 
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materials.  These drawbacks could prohibit the ability to inexpensively mass-produce 
these devices for commercial applications.   
 Many biological applications have been demonstrated using microfluidic flow 
cytometry devices in order to demonstrate efficacy, and in some cases, reveal distinct 
advantages over analysis by conventional flow cytometry.  Microfluidic cytometry has 
been used for cellular phenotyping,103 bacterial analysis,45,75,104 rare cell detection,77  
monitoring cellular transfection105 and apoptosis,106 and cell cycle analysis.78  Some of 
these applications have also incorporated other processing steps such as automated 
fluorescence staining,105,106 cell culture,74 integrated cell lysis for the analysis of 
intracellular components,44,107 and cell sorting.74,76,77,82,108-110  
 
1.7  Concluding Remarks 
 Significant progress has been made over the past few decades in the development 
of highly specific targeting reagents, sample processing protocols, and multiplexed 
cytometry instrumentation to perform numerous complex analyses for various clinical 
diagnostic and monitoring applications.  Modern commercial flow cytometry instruments 
are costly and require large sample volumes such that the development of small, 
disposable devices based on this technology would have a profound impact on the cost 
and accessibility of diagnostic and monitoring assays.  Microfabrication technologies 
allowing for the inexpensive, reproducible production of small, disposable devices 
provide an ideal platform for the development of a point-of-care diagnostic device.  
Microfluidics allow for the integration of sample processing steps, presenting the 
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opportunity for automated “sample-in answer-out” analysis not currently possible with 
conventional instrumentation.  Automated sample processing and analysis is critical for 
applications in resource-limited settings where pathologists or trained technicians are not 
present. 
Flow cytometry is a rapid technique for analyzing clinical samples and 
characterizing complex cellular solutions.  It is used as the basis for numerous clinical 
diagnostic and monitoring applications that can in many instances be successfully 
implemented on substantially simpler platforms than typically employed.  For example, 
the microfabricated flow cytometer with the 2-color detection scheme described in this 
dissertation can be used for detecting leukocyte malignancies, applications in blood 
dosimetry, and HIV monitoring.  The strategy employed here was to devise a simple 
microfluidic cytometer to preserve the ability to inexpensively fabricate disposable 
devices.  One-dimensional focusing was employed to simplify the fabrication process.  In 
addition, off-chip pumping and optics were utilized for the development of a stable, 
robust instrument with inexpensive, disposable microfluidic chips for point-of-care 
applications. 
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1.8  Figures 
 
 
 
 
 
 
 
Figure 1.1  Schematic of a typical flow chamber in a conventional flow cytometry 
system, illustrating the principle of hydrodynamic focusing that ensures proper cell 
alignment for passage through a fluidic/ optical intersection. 
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Figure 1.2  Schematic of a common optical configuration for a commercial cytometry 
system.   
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CHAPTER 2: 
DESIGN AND CONSTRUCTION OF THE MICROFLUIDIC FLOW 
CYTOMETRY SYSTEM 
 
2.1  Introduction  
 A small, inexpensive flow cytometry system should be designed to simplify 
manufacturing processes and operational complexity while maintaining the ability to 
accurately characterize complex cellular mixtures.  In order to satisfy these requirements, 
the microfluidic device described in this dissertation has been designed to simplify 
fabrication and reduce pumping requirements.  The instrument is designed to utilize 
stationary optical, electronic, and pumping components off-chip and accommodate a 
disposable microfluidic device that contains the flow chamber.  As such, the optical 
configuration for this instrument is a modified version of that employed in conventional 
flow cytometers. 
 The design and construction of the microfabricated flow cytometer, the optical 
detection system, and the signal processing electronics are described in this chapter. The 
microfluidic flow chamber was designed with the aid of computational fluid dynamic 
simulations that predict hydrodynamic focusing. Optical components in the detection 
setup were configured to collect forward scattered light to allow cells to be detected and 
 
 
counted independent of fluorescent labels. Two discrete fluorescent signals could also be 
measured to differentiate cell subsets in complex mixtures via fluorescently labeled cell 
recognition elements.  Hardware and software for real-time signal processing were also 
incorporated, allowing for rapid instrument alignment using calibration beads and 
significantly reducing the amount of time necessary to analyze large experimental data 
sets. 
 
2.2  Theory 
2.2.1  Hydrodynamic Focusing 
 The relative hydraulic resistances of cell sample to sheath fluid channels must be 
properly designed for a hydrodynamic focusing chamber where fluid flow is driven by a 
vacuum source. This is necessary to ensure the proper hydrodynamic focusing required 
for the specific application is achieved.   The chip described in this dissertation utilizes a 
single input reservoir for the sheath buffer solution. This solution is split into two streams 
that recombine after they intersect the cell sample solution as shown in Figure 2.4a.  The 
proper ratio of hydraulic resistances of the channels was calculated using Equations 2.1 
and 2.2 to achieve the desired hydrodynamic focusing effect.  Equation 2.1 was set equal 
to 0.15, which is the desired ratio of cell to sheath channels to obtain cell stream focusing 
to a width of 10 µm.  Since all channel depths are equal on the device, channel lengths 
and widths were tuned to achieve the proper flow rate ratio.   
Flow rate ratio ൌ  
QC
QC ൅  2QS
                                                                                               ሺ2.1ሻ 
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QC is the cell solution flow rate and QS is the sheath buffer flow rate.  The flow rate Q is 
defined in Equation 2.2. 
Q ൌ  
∆Pwdଷ
12ηL
                                                                                                                                 ሺ2.2ሻ 
In this equation, ∆P is the applied pressure drop, w is the channel width, d is the channel 
depth, η is the solution viscosity, and L is the channel length.  Applying Ohm’s law to 
Equation 2.2—substituting the ratio of channel length to area for hydraulic resistance—
and cancelling out constant terms such as channel depth and solution viscosity allows the 
flow rate ratio to be expressed in terms of channel lengths (L) and widths (w) as shown in 
Equation 2.3. 
QB
ܳC
ൌ  
LCwB
LBwC
                                                                                                                                  ሺ2.3ሻ 
For the device described here, the flow rate ratio QB
ொC
 in Equation 2.3 was set equal to 3 
based on the desired flow rate, and channel lengths and widths determined. 
 
2.2.2  Laser Beam Shaping 
 The incident laser beam was shaped into an elliptical profile with the long axis 
orthogonal to the cell flow direction to increase the reproducibility of the time each cell 
spends in the excitation beam.  Beam shaping was accomplished using a pair of crossed 
cylindrical lenses, where each cylindrical lens is used to focus the beam in one direction.1  
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The properties of the lens pair required for this setup was calculated using Equation 2.4 
based on the desired final focused elliptical beam profile,     
ݓF ൌ  
ߣ݂ܯଶ
ߨݓL
                                                                                                                                 ሺ2.4ሻ 
where ݓF is the desired radius of the focused beam, ߣ is the laser wavelength, ݂ is the 
focal length of the cylindrical lens, ܯଶ is the quality factor of the incident beam (assumed 
to be 1.0), and ݓL is the radius of the beam at the laser output.  A final focused beam 
profile of 15 µm by 100 µm was chosen to ensure that cells experience minimal variation 
in excitation time due to small deviations in their location relative to the center of the 
beam.  Uniformity of measurements is ensured by aligning the long axis of the focused 
beam over the entire width of the center cell stream channel.  In addition, the focused 
beam profile was chosen to reduce the probability of having more than one cell in the 
excitation beam simultaneously. 
 
2.3  Microchip Design 
 The microfluidic device was intended to achieve proper hydrodynamic focusing 
of the cell solution using a simple design.  Glass chips were used due to their relative 
robustness, optical transparency, and compatibility with low-pressure driven flow.  One 
dimensional focusing is utilized to simplify chip fabrication.  In addition, all channels 
(i.e. the sheath buffer channels and cell solution channels) were etched to the same depth 
in a single etch step to provide the desired channel dimensions.  Further, all fluid flow is 
driven by applying sub-ambient pressure to a single channel.  This eliminates the need for 
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two pumps that are commonly employed to supply independent control of the cell sample 
and sheath flow rates using positive pressure.   
 When manipulating fluid using pressures, it is important to understand the fluid 
flow profile and consider how it will impact the cells traveling on-chip.  The effects from 
pressure-induced parabolic flow do not need to be considered in the plane focused by the 
sheath buffer since the sidewall drag forces predominantly act on the outer-sheath fluid 
stream.  In the device described using one-dimensional hydrodynamic focusing, it is 
however necessary to consider how the parabolic flow profile effects the cell stream 
solution in the vertical dimension not focused by the sheath flow.  Different fluid 
velocities within this stream caused by the parabolic flow profile can cause the cells to 
travel at different speeds, increasing the variance in cell excitation and detection times.  
In order to reduce this effect, the channel depth can be minimized.  The cells will then 
experience the flow profile near the walls where the flow is slower, and in the center of 
the channel at the maximum fluid velocity.  The result is that the cells will travel at a 
velocity equivalent to the average fluid velocities across the parabolic flow profile.  An 
issue with minimizing the channel depth is that the channels can quickly clog with cells, 
cell debris, or particulate contaminants, rendering the microfluidic device inoperable.  For 
applications described in this dissertation concerning blood cell solutions, channel depths 
of 20-25 µm were chosen as a compromise between minimizing the parabolic flow 
effects and reducing the possibility for channel clogging. 
Calculations to determine the optimal ratio of hydraulic resistances of cell 
solution flow to sheath channel flow along with computational fluid dynamic simulations 
were employed on prospective flow chamber designs to ensure proper hydrodynamic 
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focusing.  Adequate hydrodynamic focusing for the application was defined by the ability 
to focus the cell solution to a width close to 10 µm.  After calculating the proper ratios of 
channel hydraulic resistances using Equations 2.1, 2,2, and 2.3, designs incorporating 
different intersecting angles of sheath buffer channels to cell solution channels were 
simulated.  The results are shown in Figures 2.1-2.3.  A 90º angle of intersection as 
shown in Figure 2.1 has been described previously in the literature for microchip 
cytometry applications.2  Figure 2.2 shows a simulation of a 35º angle of intersection, 
which closely resembles the focusing strategy employed in most commercially available 
capillary based cytometry systems.  Figure 2.3 is the result from a 135º angle intersection 
simulation.  The hydrodynamic focusing properties demonstrated by these simulations 
led to the selection of the channel layout in Figure 2.3 as the optimal design for the 
microfluidic cytometry flow chamber.  This design has maximum sheath channel widths 
of 465 µm and a sample cell channel width of 70 µm. 
Figure 2.4a shows an image of the final microfluidic cytometry chip design with 
arrows indicating fluid flow direction.  The size of the monolithic glass device is 25.4 
mm x 50.8 mm x 1.8 mm.  The chip uses a vacuum source applied at a single sample 
waste port (SW) to control the fluid flow from both the sample cell (SC) and sheath 
buffer (SB) channels.  Using a single vacuum source is advantageous as it reduces off-
chip complexity compared to applying positive pressure at both SC and SB to drive flow.  
Another advantage is that the focused sample cell stream dimensions at the detection 
region are relatively independent of the fluid velocity—given the diffusion coefficient of 
a lymphocyte—and will therefore not depend significantly on the magnitude of the 
applied sub-ambient pressure.  This is a result of the constant ratio of sheath to sample 
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fluid flow, defined by the channel architecture.  Consequently, the chip can be run at 
different analysis rates through control of the single vacuum source without affecting the 
focused stream profile.  A third advantage is that by splitting the sheath buffer flow into 
identical focusing channels (f1, f2), a symmetrically focused stream at the detection 
region results since the flow rates in f1 and f2 are identical.  Figure 2.4b shows a 
photograph of the microfluidic device in operational form with glass reservoirs attached 
for introducing sheath and cell solutions and a threaded nanoport attached for applying 
vacuum to the device. 
 
2.4  Experimental 
2.4.1 Computational Fluid Dynamic Simulations 
 Microchannel architectures were modeled using Coventorware fluid dynamic 
simulations software (Coventor, Cary, NC) to allow in silico optimization of the 
hydrodynamic focusing performance.  Simulations were performed for prospective flow 
chamber designs by modeling the hydrodynamic focusing intersection of a dye solution 
having a diffusion coefficient of 2.6 x 10-6 cm2 s-1—instead of a solution containing 
suspended cells—with water when sub-ambient pressure is applied below the 
intersection.  Simulated fluid flow was achieved through the application of 10-3 torr of 
pressure below the intersection of the cell and sheath solutions.  
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2.4.2 Microchip Fabrication 
Glass microfluidic chips were fabricated using standard wet chemical etching 
techniques as described previously.3-5  White crown glass substrates (B270) coated with 
chromium and positive photoresist (Telic Co., Valencia, CA) were patterned with the 
chip design by flood UV exposure using a custom photomask (Photoplot Store, Colorado 
Springs, CO).  After photoresist development (MF-319; Microchem, Newton, MA) and 
removal of exposed chromium (Chromium Etchant; Transene, Danvers, MA), channels 
were etched into the glass substrate using a dilute HF/NH4F solution (10:1 Buffered 
Oxide Etch; Transene).  Etching was allowed to proceed until the desired dimensions 
were obtained as determined by profilometry (P-15; KLA-Tencor, San Jose, CA).  The 
etched substrates were then diced and access holes made by powder blasting (Comco 
Inc., Burbank, CA).  All glass was then thoroughly cleaned by sonication in a 5% 
solution of Contrad (Fisher, Waltham, MA) for ten minutes, followed by immersion in 
Nanostrip solution (Cyantek Corp., Fremont, CA) for 30 minutes.  Etched glass substrates 
and glass cover plates were then hydrolyzed in a 2:2:1 solution of H2O/NH4OH/H2O2 for 
30 minutes at 70°C, and thermally bonded at 550°C for ten hours.  Buffer and cell 
solution reservoirs were made by attaching glass cloning cylinders (Fisher) over via holes 
using a two-part epoxy.  A poly(etheretherketone) (PEEK) nanoport fitting (Upchurch 
Scientific, Oak Harbor, WA) was attached to the microchip waste port in order to apply 
sub-ambient pressure for fluid manipulation.  A 10/32 threaded PEEK fitting was used to 
attach the nanoport to a segment of 0.04’’ ID PEEK tubing for connection to a Venturi 
style vacuum pump (Vaccon, Medfield, MA).  
 
36 
 
2.4.3  Surface Modification  
To reduce cell and cell debris adhesion to the microfluidic channel walls, a thin 
coating of polyethylene glycol (PEG) was covalently attached to all the channels.  A 
modified procedure from that described by Razunguzwa et al.6 was employed for the 
PEG coating.  First, 1 N NaOH was drawn through the channels for 30 minutes to 
hydrolyze the glass surface.  The chip was then flushed with Nanopure H2O for 10 
minutes, dried by pulling air through the chip, followed by flushing with dry toluene for 5 
minutes.  The channels were filled with a solution of N-(triethoxysilylpropyl)-O-
polyethylene oxide urethane (MW= 500) (120 mg/mL)  (Gelest Inc., Morrisville, PA) in 
toluene and left to react at room temperature for 8 hours.  The chip was then flushed with 
toluene for 5 minutes and dried at 80 °C for 3 hours. 
 
2.4.4  Optical Instrumentation 
Laser excitation was obtained using a 488-nm solid-state laser (40 mW) (Cyan; 
Newport Corp., Irvine, CA).  Fluorescence and scatter signals were collected using a 40x 
microscope objective (NA=0.45) (Creative Devices Inc., Neshanic Station, NJ). Optical 
filters including dichroic mirrors, band-pass filters, and long-pass filters were purchased 
from Semrock (Rochester, NY). The elastic scatter signal was detected using a 
photodiode detector (Thorlabs Inc., Newton, NJ).  Fluorescence signals were spatially 
filtered using a 400-µm slit (Thorlabs Inc., Newton, NJ), and directed to photomultiplier 
tubes for detection (PMT) (H6780; Hamamatsu Photonics, Bridgewater, NJ).   
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A schematic of the optical detection configuration is shown in Figure 2.5, and a 
photograph of the detection system is shown in Figure 2.6.  The 488-nm solid-state laser 
(40 mW) was focused to an elliptical spot (15 µm x 100 µm) from above the chip using a 
pair of crossed cylindrical lenses.1   A photograph of the crossed cylindrical lens pair is 
shown in Figure 2.7a.  A 40x microscope objective (NA=0.45) was positioned under the 
microchip for the collection of fluorescence and elastic scatter.  The elastic scatter signal 
is separated from the fluorescence by passing the collected light through a 495-nm cutoff 
dichroic mirror.  The reflected scatter signal is then directed to a photodiode for 
detection.  The transmitted fluorescence light is spatially filtered using a 400-µm slit, and 
then passed through a 493-nm long pass filter to remove any incident laser light.   
Common fluorescent markers used in combination with 488-nm laser excitation 
include FITC, AF488, PE, Calcein, and PerCP as well as tandem dye conjugates such as 
PE-Texas Red, PE-AF610, PE-Cy5 and PerCP-Cy5.5.  This instrument is generally 
configured to detect FITC with a tandem dye such as PE-Texas Red.  For this specific 
application, a 593 nm cutoff dichroic mirror splits the incident fluorescence into two 
channels, followed by band-pass filtering before detection with separate PMT’s.  FITC 
fluorescence signals are passed through a bandpass filter with a maximum transmittance 
of 536-nm with a 40-nm bandwidth, while PE-Texas Red fluorescence is passed through 
a 624-nm maximum transmittance filter also having a 40-nm bandwidth.     Figure 2.7b 
shows a photograph of the fluorescence detection region of the instrument, showing a 
filter wheel mounted in front of each PMT to easily modify the spectral detection 
capabilities of the instrument by changing the band-pass filters based on the specific 
fluorescent molecule pair employed. 
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2.4.5  Signal Processing 
Current outputs from each PMT are amplified through individual low-noise 
current preamplifiers (SR570; Stanford Research Systems, Sunnyvale, CA), and digitized 
using a 16-bit multifunction I/O card (PCI-6251 National Instruments, Austin, TX).  A 
14-bit high speed digitizer (National Instruments PXI-5122) has also been incorporated 
for experiments where long acquisition times and acquisition rates over 1 MHz are 
required.  Data acquisition and the extraction of cell signal information from raw data 
was performed using custom LabVIEW (National Instruments) programs. 
 Current signals output from the PMT’s and photodiode detectors were passed 
through a current to voltage amplifier, and resulting voltage signals were transferred to a 
data acquisition card.  Custom LabVIEW software was used to save data output from 
each detector, and process raw data signals in order to extract event information.  Raw 
fluorescence and scatter data from each channel was analyzed in LabVIEW to find 
signals above a defined threshold.  The optical signals in each channel were then 
correlated, and peak intensities and areas are extracted to display as distribution 
histograms and scatter plots.  Screen captures, photographs, and descriptions of the 
hardware and software programs used are displayed in Appendices.    
 
2.5  Conclusions 
 Efforts to design and construct the microfluidic cytometry device and optical 
detection configuration were described in this chapter.  To design a flow chamber that is 
driven solely by applying a sub-ambient pressure, calculations were performed to ensure 
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the proper ratio of cell to sheath channel hydraulic resistances were achieved to obtain the 
desired hydrodynamic focusing properties.  Computational fluid dynamic simulations 
were used in combination with these calculations to determine the optimal focusing angle 
at the intersection of sheath buffer and cell solutions in the flow chamber.   
 The optical detection system assembled was based on a simplified version of 
state-of-the-art cytometry optical designs, maintaining the capacity to simultaneously 
detect forward scattered light and two fluorescence channels from individual cells.  
Further, the system was constructed to facilitate rapid removal of the microfluidic device 
for disposable applications.  In addition, the instrument was designed to easily vary the 
fluorescence detection characteristics of the system through the use of filter wheels and 
cage cube systems from which filters can be quickly substituted.   
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2.6  Figures 
 
 
 
 
Figure 2.1  Result from a computational fluid dynamic simulation of a prospective 
microfluidic flow chamber design where the sheath buffer intersects the cell solution at a 
90º angle. 
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Figure 2.2  Result from a computational fluid dynamic simulation of a prospective 
microfluidic flow chamber design where the sheath buffer intersects the cell solution at a 
35º angle. 
42 
 
  
A                  B 
                 
 
Figure 2.3  Result from computational fluid dynamic simulation of a prospective microfluidic flow chamber design where the sheath 
buffer intersects the cell solution at a 135º angle.  
 
Figure 2.4  (A) Photograph of the glass microfluidic device loaded with dye for better visualization of the channels.  (B) Photograph 
of the microfluidic device in operational form with glass cylinders secured to the chip over the sheath buffer (SB) and cell solution 
(SC) reservoirs, and a threaded PEEK nanoport attached over the sample waste (SW) channel for vacuum connection. 
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 Figure 2.5  Schematic diagram of the optical detection setup of the microfluidic cytometry instrument for the detection of two 
fluorescence channels and forward-scattered light. 
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Figure 2.6  Photograph of the microfluidic flow cytometry detection system assembled on an optical table within a dark box.   
Figure 2.7  (A) Close-up photograph of the laser beam focusing optical lenses.  (B) Photograph of the fluorescence detection region of 
the optical assembly including the filter wheels for quickly changing the bandpass filters in front of each PMT.  
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CHAPTER 3:  
CHARACTERIZATION OF THE MICROFLUIDIC FLOW CYTOMETRY 
SYSTEM 
 
3.1  Introduction  
 The instrument described in this dissertation was designed with specific 
performance objectives.  One objective was to ensure proper hydrodynamic focusing of 
cells on-chip to facilitate accurate flow cytometry measurements.  Another goal was to 
maximize the cell throughput possible using the microfluidic instrument.  An additional 
criterion for this instrument was to have fluorescence detection precision rivaling that of 
commercial instrumentation.  A final goal was to develop and characterize scatter-based 
detection for label-free identification of cells or particles with accurate size-based 
discrimination.  
This chapter focuses on the initial experiments designed to characterize the 
hydrodynamic focusing properties, cell throughput, fluorescence detection precision, and 
scatter detection performance of the microfluidic flow cytometer.  Optical imaging, 
confocal imaging, fluorescent microbead analysis, and fluorescently labeled cells were 
employed to characterize the performance characteristics of the instrument. 
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3.2  Experimental 
3.2.1  Optical Imaging 
Optical images shown were obtained with an inverted microscope (TE300; Nikon, 
Melville, NY) equipped with a high-pressure mercury arc lamp using 10 - 40x objectives,  
and a CCD camera (NTE/CCD-512-EBFT; Roper Scientific, Trenton, NJ) using IPlab 
Spectrum acquisition software (Scanalytics Corp., Vienna, VA).  Confocal microscopy 
images were taken with a Zeiss 510 Meta laser-scanning confocal microscope (Zeiss, 
Thornwood, NY) using 10x or 60x water immersion objectives. 
 
3.2.2  Cell Handling   
Human Jurkat T-cell lines (TIB-152) (American Type Culture Collection, 
Rockville, MD) were cultured in RPMI 1640 media supplemented with 10% by volume 
fetal calf serum, penicillin (100 IU/mL), and streptomycin (100 µg/mL) (Invitrogen 
Corp., Carlsbad, CA).  Cell washing and staining were done in phosphate buffered saline 
(PBS) (pH=7.4) supplemented with fetal calf serum (BD Biosciences, San Jose, CA).  
The cells (≈106) were washed with 500 µL of the PBS solution and then pelleted by 
centrifugation at 300x g. The supernatant was discarded and the washing procedure 
repeated two times before the cells were finally dispersed in 50 µL of the supplemented 
PBS buffer.  Cells were then labeled with an intracellular fluorescent dye by incubating 
them at room temperature with 2 µL of Calcein-AM (1 µg/mL) (Invitrogen Corp.) for 30 
minutes. 
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3.2.3  Cytometry Comparison Experiments   
To evaluate precision, commercially available 6-µm diameter BODIPY doped 
calibration beads (AlignFlow Plus; Invitrogen) were analyzed on both the 
microfabricated cytometer and a commercial Cyan ADP flow cytometry system 
(Beckman-Coulter, Fullerton, CA).  Optical filters in the microfluidic instrument were 
chosen to duplicate those used in the FL1 and FL3 Cyan system fluorescence channels. 
 
3.3  Results 
3.3.1  Characterizing Hydrodynamic Focusing Performance 
To experimentally assess the hydrodynamic focusing characteristics of the 
microfluidic flow chamber, a fluorescent dye solution was introduced on-chip at the cell 
sample reservoir, water was input at the sheath buffer reservoir, and vacuum was applied 
at the sample waste reservoir.  This investigation was an experimental verification of the 
computational fluid dynamic simulations described in Chapter 2.   Figure 3.1a shows the 
resulting fluorescent image of Rhodamine B dye focused at the intersection of the cell 
sample channel and focusing channels.  Figure 3.1b shows a 60x magnified image of the 
focused Rhodamine B dye stream as it enters the analysis channel.  A line profile taken at 
the detection region 2 mm below the intersection of the cell and focusing streams shows 
the dye is hydrodynamically focused to a width of 9 µm.  This result corroborates the 
result of the computational fluid dynamic simulations, and verifies that the flow chamber 
effectively focuses the cell stream to the approximate diameter of a lymphocyte.   
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In addition to investigating the flow profile in the xy-plane, confocal imaging was 
utilized to examine the cell stream profile after hydrodynamic focusing in the z-plane 
through the depth of the microchannel.  A xz-profile was acquired by taking optical 
measurements translating through the depth of the channel in 2.0 µm steps.  The resulting 
stacked image is shown in Figure 3.2.  In this experiment, a solution of Rhodamine B 
(red) was introduced into the sheath buffer channel, and a solution of FITC dye (green) 
was introduced at the cell sample input.  This result reveals that the width of the focused 
FITC profile remains constant throughout the depth of the microchannel.  This result also 
confirms that there is no focusing occurring in the z-plane, as expected.  
Hydrodynamic focusing of cells was investigated by introducing a solution of 
Calcein labeled Jurkat cells into the cell sample reservoir and using PBS buffer as the 
sheath fluid.  Figure 3.3 shows a 1-second time-integrated CCD image of the 
fluorescently-labeled Jurkat cells (107/mL) hydrodynamically focused into a single file 
on-chip.  The slightly wider lateral trajectories of the cells compared to the dye molecules 
at the entrance to the focusing region can be attributed to their larger momentum 
compared to the dye molecules.  Nonetheless, the cells are adequately focused into single 
file as they enter the center analysis channel downstream from the sheath fluid 
intersection.  
 
3.3.2  Cytometry Measurement Precision 
AlignFlow Plus fluorescent beads having minimal bead-to-bead intensity 
variation were run on the microfluidic cytometry chip and a Beckman-Coulter Cyan ADP 
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flow cytometer in order to compare system measurement precision.  Comparisons of 
precision were performed by evaluating the coefficients of variation (CV), defined as the 
quotient of the standard deviation of the bead intensities and the mean detected bead 
intensities, obtained from both systems.  The fluorescence emission of the beads covers a 
wide spectrum (515-660 nm) that is detectable by both the green and red fluorescence 
channels of both systems.  The beads were run at a throughput rate of 120 Hz with more 
than 10,000 beads counted over the course of 90 seconds.   
Figure 3.4a displays a segment of the raw PMT data showing the detection of 
numerous beads in the green fluorescence channel of the microfluidic cytometry system.  
Figure 3.4b is a histogram showing the intensity distribution (arbitrary units) of the data 
shown from the analysis of the same beads detected in Figure 3.4a with the green 
fluorescence channel.  Figure 3.5 is a two-color scatter plot for the dual channel detection 
of the calibration beads, showing narrow intensity distributions in both channels as seen 
by the tight grouping of the detected events.  The resulting histogram has a semi-
Gaussian profile with a CV of 5.9% in the green detection channel.  Using the Cyan ADP 
system, a CV of 4.4% was obtained.  The manufacturer reports a CV of 4.4% as 
determined using a FACScan flow cytometry system.   
The higher CV value for the microfluidic system compared to both the Cyan and 
manufacturers’ value is most likely due to the planar focusing scheme used for the 
microchip compared to the focusing used in the commercial instrumentation or other 
microfluidic designs.1  For the microchip described here, the beads lateral position—
within the plane of the chip—in the detection region should remain constant due to the 
focused stream; however, the bead position in the z-plane—normal to chip plane—can 
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vary within the channel depth leading to small variations in the velocity of the bead.  
These variations result in changes in the measured bead intensity since slower beads 
remain in the detection region longer than faster traveling beads.  This effect can be 
minimized by reducing the channel depth but at the cost of increasing the possibility of 
chip failure by fouling or clogging as the channel depth approaches the cell size.  As a 
compromise, a channel depth between 15-20 µm was used for the analysis of cells on the 
order of 10-µm in diameter.  Alternatively, the depth of focus of the collection optics—
which is ≈1.2-µm as currently configured—could be increased by reducing the numerical 
aperture at the cost of reduced light collection. 
 
3.3.3  Assessment of System Throughput 
The initial design goal for the throughput of the vacuum driven system was to 
analyze cells at rates above 1 kHz.  While this objective is not close to commercial 
system throughput, the purpose was to generate sufficient cell counts within a short time 
period (less than 30 minutes total) to successfully compare results to those obtained using 
commercial systems.  The cellular throughput was determined by analyzing a 100-µL 
solution of cultured Jurkat cells (107/mL) labeled with the intracellular fluorescent dye 
Calcein.  The cell solution was pulled through the chip with a pressure differential of 
approximately 100 torr.  Figure 3.6 shows the detection of 5 individually resolved Jurkat 
cells in less than 2 ms using a single fluorescence channel.  The entire experiment 
resulted in the detection of over 22,000 cells during a 10 second acquisition.  Detected 
cells had an average linear velocity of approximately 12 cm/s.  These results demonstrate 
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cellular detection at a throughput greater than 2 kHz.  Furthermore, fluorescently doped 
2-µm diameter polystyrene beads have been detected at rates greater than 5 kHz using the 
same vacuum driven system, indicating higher cellular throughputs can be achieved using 
increased cell or particle concentrations and by realizing higher flow rates.  
One method to achieve higher flow rates, and therefore higher analysis throughput 
is by using positive pressure to drive fluid.  This can be accomplished using the same 
microfluidic device described, except threaded nanoport fittings must be secured to the 
sheath buffer and cell sample inputs.  Generated pressure differentials and fluid flow rates 
can be significantly increased over the vacuum driven system using this approach.  Figure 
3.7 shows the result obtained from the detection of Calcein labeled SUP-T1 cells pushed 
through the microfluidic cytometry chip at a concentration of 4 million cells per mL.  
This result shows the detection of 3 individually resolved cells in less than 200 µs.  The 
flow rates applied to the sheath and cell inputs were 350 µL/min and 100 µL/min, 
respectively.  Cell velocities were measured to be approximately 75 cm/s.  This 
experiment resulted in the detection of over 105 cells in a period of 10 seconds, indicating 
a throughput of approximately 12 kHz. 
 
3.3.4  Scatter Based Detection  
In addition to fluorescence based cellular detection, light scattering methods can 
be used for cellular detection independent of luminescent probes.  Scatter signals can help 
simplify experiments as one less fluorescent probe is necessary for cellular detection, and 
can be particularly useful for size-based cell type discrimination.  Additionally, scatter 
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based cellular detection is commonly used to trigger data acquisition in the fluorescence 
channels in order to avoid collecting unnecessary data when no cells are present in the 
detection region.  Forward scatter and extinction have been demonstrated using this 
system for cellular detection and size-based discrimination.  A 1:1 mixture of 5.7-µm and 
9.8-µm diameter FITC doped polystyrene beads was analyzed on-chip in order to 
demonstrate that forward scatter and extinction based detection can be used for cell sizing 
and label-free cellular enumeration.  Figure 3.8 shows the detection of a 9.8-µm bead 
followed by a 5.7-µm bead, identified as peaks in the bottom fluorescence trace and small 
forward scatter peaks followed by extinction valleys in the top scatter trace.  Since the 
amplitude of the scatter intensities are related to the square of the detected bead radius, 
the size of the beads for each detected event was confirmed by ensuring that the ratio of 
the extinction valley depths corresponded to the expected difference between the 5.7 and 
9.8 µm beads.  The average ratio of the signal amplitudes was 3.2 ± 0.3, which is 
statistically the equivalent to an expected ratio of 3.0 (p > 0.05, 95% confidence limit).   
 
3.4  Conclusions 
 The microfluidic cytometry instrument was designed to operate as a simple, 
miniaturized version of large-scale commercial cytometers.  As such, some design 
criteria were developed to ensure comparable instrumental operation.  The fluidic 
focusing features contained within the glass microchip were designed to focus the cell 
sample stream to a width of 10-µm, and this result was verified using an inverted 
fluorescence microscope to characterize the focused profile of a dye solution on-chip.  
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Confocal microscopy was used to further characterize the hydrodynamic focusing 
properties of the microfluidic flow chamber by stacking multiple images to reveal the cell 
stream profile throughout the depth of the microchannel.  Further experiments were 
performed using fluorescently labeled cells to confirm that cells are effectively focused as 
they enter the analysis channel.  These results indicated that the microfluidic device 
adequately focuses the cell stream to a width of 9-µm and confirmed that the cells are 
aligned in single-file as they enter the laser interrogation region of the analysis channel. 
 Measurements of fluorophore doped polystyrene alignment beads were made to 
test the precision of the microfluidic cytometer.  The small variation in detected signal 
from bead to bead confirms that the time each bead spends in the laser interrogation and 
detection region is reproducible.  The CV values obtained from detecting the beads using 
the microfluidic system were similar to those obtained using a commercial system, 
indicating that the measurement precision is close to that obtained using the commercial 
system.  A consequence of the slightly higher CV values obtained using the microfluidic 
system is lower resolving power. However, this difference should not be significant 
enough to preclude the utility of the system for many biological diagnostic and 
monitoring applications. 
 To ensure that the microfluidic system could operate fast enough to characterize a 
biological sample within 30 minutes, system throughput was evaluated.  Using vacuum to 
manipulate fluids on-chip, a throughput of 2 kHz was observed, which is sufficient for 
many applications.  With positive pressure the observed system throughput was greater 
than 12 kHz.  This enhanced throughput may prove necessary for applications that 
require the rapid analysis of large sample volumes to enumerate rare cells.  Two pumps 
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are required for fluid delivery using positive pressure, however, instead of one for 
vacuum operation. 
 Light scatter based detection was demonstrated on-chip for many purposes.  First, 
elastic light scatter can be used to detect cells or particles without the use of any extrinsic 
labels.  In addition, the scatter signal can be used to trigger data acquisition to reduce the 
amount of raw data that requires processing. Finally, light scatter can be used to 
differentiate cells or particles based on size.  A mixture of two different sizes of 
fluorescently doped beads was analyzed using the microfluidic system to effectively 
demonstrate the ability to detect cells or particulates independent of fluorescent labels 
and to differentiate them based on size.   
 The experiments described in this chapter were devised to characterize the 
operational performance of the microfluidic cytometry system.  The results were used to 
demonstrate instrument functionality and ensure that design criteria were either met or 
exceeded.  It is important to point out that parameters such as measurement precision and 
throughput are lower than commercial systems, and scatter based detection capabilities 
are more limited because side scatter is not detected.  This restricts the number of 
applications for the instrumentation relative to conventional cytometry.  However, the 
performance of the microfluidic system is sufficient for many biological applications, 
some of which were explored.  These will be discussed in the remaining chapters of this 
dissertation. 
   
 
  
3.5  Figures 
 A          B 
       
Figure 3.1  Optical images obtained using the Zeiss 510 Meta confocal microscope to characterize the hydrodynamic focusing 
properties of the microfluidic flow chamber. Vacuum was applied below the sheath buffer and cell sample intersection. (A)  
Magnified image (10x) of Rhodamine B hydrodynamically focused with water.  (B)  Magnified image (60x) of the hydrodynamically 
focused Rhodamine B dye solution as it enters the analysis channel. 
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Figure 3.2  Stacked confocal xz-profile using Rhodamine B sheath solution (red) and 
FITC dye (green) in the sample stream to investigate the fluid profile below the 
hydrodynamic focusing intersection on the microfluidic flow chamber.     
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Figure 3.3  Time-integrated (1-sec) CCD image of an operating microfluidic flow 
cytometry chip taken to investigate hydrodynamic focusing properties. PBS buffer was 
introduced in the sheath buffer reservoir and a solution of Calcein labeled Jurkat cells at 
the cell sample input. 
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Figure 3.4  (A)  Raw PMT data for the detection of multiple individually resolved 6-µm 
AlignFlow Plus fluorescent beads using the red fluorescence channel in the microfluidic 
cytometry system.  (B) Peak intensity distribution obtained for the detection of the same 
beads using the green fluorescence channel. 
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Figure 3.5  Scatter plot showing the result for dual-channel detection of 6-µm AlignFlow 
Plus calibration beads using the microfluidic system. 
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Figure 3.6  Result for the detection of Calcein labeled Jurkat cells using the microfluidic 
cytometry system and vacuum driven flow to determine throughput. Five cells were 
detected in less than 2 ms.  
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Figure 3.7  Result for the detection of Calcein labeled SUP-T1 cells using positive 
pressure driven flow on the microfluidic cytometry system.  Three cells were detected in 
less than 200 µs.  
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Figure 3.8  Detection of a mixture of 5.7-µm and 9.8-µm diameter FITC doped beads 
using scatter based detection (blue trace) and fluorescence (red trace).   
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CHAPTER 4:  
IMMUNOPHENOTYPING ON-CHIP 
 
4.1  Introduction  
 Blood cell characterization is important in the detection and monitoring of a 
number of disease states including HIV, leukemia, and lymphomas as concentrations of 
specific cell subsets can vary considerably from normal levels in infected patients.1-4 
Cellular discrimination based on surface protein expression is also valuable for the 
detection of rare circulating tumor cells in blood.5 Therapeutic efficacy and dosage 
requirements may also be determined by monitoring the modulation in cell counts.  On-
chip monitoring of these changes in blood cell concentrations may prove valuable for 
rapid, inexpensive diagnostic and monitoring applications. 
The differentiation of cell subsets in complex mixtures is a key aspect of most 
clinical flow cytometry applications.  Populations of cell subsets have specific antigens 
present on their surfaces, allowing for direct labeling and identification using antibody 
probes conjugated to fluorescent dyes.  Polyclonal antibodies can be utilized to 
simultaneously detect numerous cell subsets, while monoclonal antibody probes can be 
used for direct targeting and detection of a single cell subset.  Conventional flow 
cytometry allows for the rapid characterization of cell populations by 
 
 
immunophenotyping through the use of multiple fluorescently tagged antibodies.  
Instruments equipped with multiple fluorescence detection channels simultaneously 
detect multiple fluorescent signals on individual cells.  In addition, solutions containing 
various cell types can be effectively characterized using multiple detection channels for 
each cell type.  This allows for the rapid discrimination of cell subsets in complex cell 
mixtures such as blood, facilitating the widespread use of flow cytometry in clinical 
diagnostics. 
Experiments testing the immunophenotyping capabilities of the microfluidic flow 
cytometry system are described in this chapter.  Cultured cell mixtures and solutions of 
peripheral blood mononuclear cells were used to characterize the ability of the 
microfluidic system to differentiate cell types based on the presence of cell surface 
antigens using fluorescently labeled antibody probes.  Results from the two-color 
microfluidic system were then compared to results obtained from a commercial 
cytometer to verify the accuracy of the microfluidic systems’ immunophenotyping 
measurements. 
 
4.2  Experimental 
4.2.1  Cell Handling and Labeling 
Human leukemic lymphoblasts (CCRF-CEM) and Jurkat cells (TIB-152) 
(American Type Culture Collection, Rockville, MD) were cultured and washed as 
previously described in section 3.2.2. Fluorescently labeled antibodies for CD3, CD4, and 
CD8 (5 µL) (Invitrogen) were added to the cell solutions, which were then incubated for 
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30 minutes in the dark with continuous mixing.  Labeled cells were then washed and 
centrifuged twice, and redispersed in Cytofix buffer (BD Biosciences).  The final cell 
concentration used for microchip experiments was 107/mL. Experiments performed to 
compare microchip results with a commercial cytometer utilized cell solution 
concentrations of 2 x 106 cells/mL. 
 
4.2.2  Preparation of Peripheral Blood Mononuclear Cells 
Whole human blood treated with the anti-coagulant heparin (Research Blood 
Components, Brighton MA) was purchased and processed to obtain enriched peripheral 
blood mononuclear cell (PBMC) samples for analysis.  A standard density gradient 
separation was performed using Ficoll-Paque Plus (GE Healthcare, Uppsala, Sweden) to 
selectively remove unwanted erythrocytes and platelets.  This was done by adding 1 mL 
of whole human blood to a tube containing 1.5 mL Ficoll and 1 mL PBS supplemented 
with 2% Fetal Bovine Serum, followed by centrifugation at 400g for 30 minutes.  The 
layer of mononuclear cells between the plasma and ficoll media was carefully removed 
and washed with PBS.  Remaining mononuclear cells were counted using a 
hemacytometer and labeled in the same manner as previously described.   
 
4.2.3  Cytometry Comparison Experiments   
To evaluate the immunophenotyping accuracy of the microfabricated cytometer, 
results were compared to the Cyan ADP flow cytometry system.  Solutions of prepared 
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PBMC samples were analyzed on the Cyan cytometry system to determine CD4:CD8 
ratios.  Results from these analyses were then compared to results obtained from the 
analysis of the same samples using the microfluidic system. 
 
4.3  Results 
4.3.1  Immunophenotyping Cultured Cells 
Model system mixtures of cultured T-lymphocytes and mononuclear cells isolated 
from whole blood were processed on chip to specifically discriminate T-cell subsets 
based on CD3, CD4, and CD8 antigen expression.  The enumeration of these particular 
cell subtypes is important for monitoring HIV progression since the relative amount and 
concentration of CD4+ lymphocytes, and the CD4:CD8 ratio is correlated to disease 
progression and can affect treatment selection.6 
Figure 4.1a shows the result for the detection of a 1:1 mixture of cultured Jurkat 
T-cells (CD3+) and CCRF-CEM human T-cells (CD3+, CD4+).  FITC-labeled anti-CD3 
and PE-AF610 labeled anti-CD4 antibodies were used to discriminate between the cell 
lines.  Since both T-cell lines are known to express CD3, the FITC fluorescence channel 
detects every cell in the mixture.  The cells expressing CD4 will exhibit a signal in both 
fluorescence channels and are double positive CCRF-CEM cells, while the cells not 
expressing CD4 are single positive Jurkat cells.  An expanded subset of the data is shown 
in Figure 4.1b, which shows the detection of two Jurkat cells and two CEM cells as 
determined by the presence or absence of the CD4 label.  A total of four 20 second 
experimental acquisitions were analyzed.  Of the total number of cells counted for the 
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four experiments, 49.1 ± 3.8% were CD4 positive CCRF-CEM cells, statistically 
equivalent to the 50% input ratio (p > 0.05, 95% confidence limit), demonstrating that 
this system can accurately determine relative cell ratios from mixtures of T-lymphocytes.  
A scatter plot showing a subset of this result is shown in Figure 4.2 where the cell types 
are grouped together and are easily distinguished from each other based on the presence 
or absence of the CD4 antibody label.   
 
4.3.2  Rare Cell Detection 
The detection of rare cells was demonstrated by analyzing the same two labeled 
cell types as described in the previous section at a ratio of 1000:1 Jurkat to CEM, 
respectively.  Cell concentrations were determined before mixing and labeling using a 
hemacytometer.  The rare cell experiment was performed to ensure the accurate 
measurement of low concentration cells in the presence of a significantly higher 
concentration of cells on-chip.  Figure 4.3a shows a result for the analysis of the rare cell 
mixture.  Figure 4.3b shows an expanded subset showing the detection of a single rare 
double-positive CEM cell from the data shown in Figure 4.3a.  The results of four 
experimental acquisitions in which approximately 8000 events were measured in each 
run reveal CEM cells were detected at an average concentration of 0.12 ± 0.06%, which 
is statistically equivalent to the expected CEM cell concentration based on the 0.1% 
sample loading (p > 0.05, 95% confidence limit), in less than four minutes per 
acquisition. 
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4.3.3  Lymphocyte Characterization From Peripheral Blood Mononuclear Cells 
The system was further tested by analyzing CD4:CD8 ratios in a sample of human 
PBMCs.  This analysis is clinically relevant for monitoring HIV progression.6  PBMC 
samples contain all leukocytes, so unlike the previous model systems, a positive 
fluorescence signal will not be present for every cell that passes through the device.  
Therefore, in addition to the two fluorescence colors for the anti-CD4 and anti-CD8 
antibodies, forward scatter signal was also collected.  The top trace in Figure 4.4 shows 
the scatter signal for the detection of the PBMC sample while the bottom traces show the 
fluorescence signal from the CD4 and CD8 antibody labeled cells.  Not all leukocytes are 
CD4 or CD8 positive, therefore a fluorescence peak is not present for each scatter peak.  
However, for each florescence peak, a scatter peak is present.  The results from the 
analysis of the same PBMC sample over 5 runs reveal an average CD4:CD8 ratio of 1.3 ± 
0.3, over the measurement of more than 2000 fluorescence events.  Each of the five runs 
took 5 minutes and utilized less than 10 µL of cell solution. The results are not 
statistically different from the ratio obtained on the Cyan system (1.4, p > 0.05, 95% 
confidence limit), suggesting that the microfluidic system can accurately measure 
clinically relevant cellular ratios in PBMC solutions.   
 
4.4  Conclusions 
 The experiments described in this chapter were designed to demonstrate the 
ability of the microfluidic system to differentiate cell subsets in mixed samples.  This was 
investigated by attempting to characterize cell mixtures through immunophenotyping, 
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which is a key technique employed in most clinical flow cytometry applications.  It is 
therefore critical that any flow cytometry system designed for clinical applications—
regardless of the instrument size, complexity, or multiplexing capability—to be sensitive 
enough to detect specific cell subsets by immunophenotyping. 
 Mixtures of cultured T-lymphocytes were labeled with fluorescently tagged 
antibodies specific to the surface proteins CD3 and CD4 for analysis using the 
microfluidic cytometry system.  These mixtures were analyzed to demonstrate the 
capability of the system to differentiate cell subsets based on the presence or absence of a 
specific fluorescently tagged antibody.  By starting with a known ratio of cells as 
determined by counting with a hemacytometer, we were able to demonstrate that the 
microfluidic system is sensitive enough to detect cell subsets based on surface antigen 
probes.  Further, the detected ratio of cell subsets in the contrived mixture was 
statistically equivalent to the initial cell mixture ratio.  The data show that the 
microfluidic system can accurately characterize the ratios of cell subsets contained within 
a mixture.  Experiments using the same labeled cells at a ratio of 1000:1 were also 
performed as evidence that the microfluidic system can accurately characterize the 
relative ratios of cell subsets having a large disparity in concentration.  These 
measurements are important to demonstrate because biological fluids such as blood 
contain many different cell subtypes present over a wide range of concentrations.   
 This chapter also discusses efforts to move towards the analysis of more complex 
biological samples.  Solutions of human peripheral blood mononuclear cells were 
analyzed using the microfluidic system to determine the CD4:CD8 T-lymphocyte ratio.  
Microchip experiments were performed in parallel with the Cyan flow cytometry system 
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in order to determine the accuracy of the microfluidic system analysis.  Results from this 
experiment demonstrate that the microfluidic system result is statistically equivalent to 
the result obtained using the commercial cytometry system.  This is an important 
outcome because this experiment demonstrates the capacity for the microfluidic system 
to accurately characterize ratios of cell subsets from real biological samples, providing a 
foundation for the application of this instrument for further analysis of biological 
samples. 
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4.5  Figures 
 
 
Figure 4.1  (A) Result from the analysis of a 1:1 mixture of CD3+ Jurkat cells and CD3+ 
CD4+ CEM cells where the blue trace shows the fluorescence signals from FITC-anti-
CD4 labeled cells, and the red trace shows the fluorescence signal from PE-AF610-anti-
CD3 labeled cells. (B)  Expanded region from the data shown in Figure 4.1a. 
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Figure 4.2  Two dimensional scatter plot extracted from the data shown in Figure 4.1 
demonstrating the separation between the two cell types based on the intensity of the 
FITC Anti-CD4 fluorescence signal. 
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Figure 4.3  (A) Result from the analysis of a 1000:1 mixture of CD3+ Jurkat cells and 
CD3+ CD4+ CEM cells where the blue trace shows the fluorescence signals from FITC-
anti-CD4 labeled cells, and the red trace shows the fluorescence signal from PE-AF610-
anti-CD3 labeled cells. (B)  Expanded region from the data shown in Figure 4.3A. 
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Figure 4.4  Detection of peripheral blood mononuclear cells using elastic light scatter 
and LIF for the determination of the CD4:CD8 ratio.  The top blue trace is the scatter 
signal, while the green and red traces show the fluorescence signals from FITC-anti-CD4 
and PE-Texas red-anti-CD8 labeled cells, respectively. 
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CHAPTER 5:  
INTEGRATING ERYTHROCYTE LYSIS AND IMMUNOPHENOTYPING ON-
CHIP FOR THE ENUMERATION OF LEUKOCYTES FROM WHOLE BLOOD 
 
5.1  Introduction  
In order to accurately investigate white blood cell populations by flow cytometry, 
erythrocytes are normally removed from whole blood.1-4  This is necessary in order to 
reduce the potential for interference by red blood cells that are approximately 103 times 
more abundant in blood than leukocytes.3,4  The process of erythrocyte removal consists 
of either differential centrifugation2 or bulk red blood cell lysis followed by 
centrifugation to remove the lysate debris from the intact leukocytes before flow 
cytometry analysis.3  These processes are performed manually, and therefore 
considerable variation in lysis efficiency is possible between sample batches.  As such, an 
automated platform for erythrocyte lysis from whole blood could rapidly provide 
consistent enriched leukocyte samples for immediate flow cytometry analysis. 
Significant efforts to develop new, inexpensive instrumentation for diagnostics 
and disease monitoring have focused on microfluidic based point of care clinical assays.5-
12  The foundation for these efforts is the low cost, portability, and small sample volume 
requirements associated with microfluidic devices.9,10  Microfluidic assays have been 
 
 
developed for cell sorting,3,13-16 identifying rare circulating tumor cells,17 and detecting 
specific plasma analytes.18,19  In addition, flow cytometry has been previously described 
on microfluidic devices for the detection of leukocytes and bacteria.20  While these 
examples provide a strong foundation for the use of microfluidics in flow cytometry 
applications, there has been little focus on the integration of flow cytometry with sample 
processing necessary for biological sample analysis.  Given the precise fluidic control 
capabilities of these devices, the development of a rapid, sample-in answer-out 
instrument could significantly increase the accuracy, efficiency, and cost effectiveness of 
clinical diagnostics.   
In this chapter, the development and initial operational characterization of a 
microfluidic device combining selective erythrocyte lysis with flow cytometry are 
described.  A diluted blood sample labeled with fluorescently tagged antibodies is infused 
onto a glass microchip where it interacts with a chemical lysis solution to selectively 
remove erythrocytes from the sample.  The lysis debris is shunted into a waste channel, 
while the remaining intact leukocytes continue through the device for laser induced 
fluorescence and elastic scatter based flow cytometric detection.  The enumeration of 
CD4 and CD8 T-lymphocytes—which is applicable to monitoring HIV progression21 and 
other immune disorders—has been chosen as a proof of concept to demonstrate the 
advantageous integration of sample processing with cytometry for automated, efficient 
leukocyte characterization from blood on-chip.   
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5.2  Experimental 
5.2.1  Microchip Fabrication 
Microfluidic devices were fabricated as described in Chapter 2.  A piece of 
polydimethylsiloxane (PDMS) (Sylgard 184; Dow Corning, Midland, MI) bonded to the 
top of the device after plasma cleaning was used to make direct tubing connections from 
syringe pumps as well as fluid reservoirs for blood and buffer.  An image of the glass 
microchip designed to combine erythrocyte lysis and cytometry is shown in Figure 5.1a.  
The sheath buffer channels are 400-µm wide with all remaining channels 80-µm wide.  
All channels in the device are etched to a depth of 20-µm.   
 
5.2.2  Detection Configuration 
 
The detection configuration used for the experiments described in this chapter is 
the same as described in Chapter 3.  Optical filters were exchanged in order to 
accommodate detection of Quantum Dot labeled antibodies.  Optical images were 
obtained with an inverted microscope (TE300; Nikon, Melville, NY) equipped with a 
high-pressure mercury arc lamp using a 20x objective,  and a CCD camera (NTE/CCD-
512-EBFT; Roper Scientific, Trenton, NJ) using IPlab Spectrum acquisition software 
(Scanalytics Corp., Vienna, VA).  Photographs of the microfluidic device were taken 
using a Nikon D70 digital camera.   
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5.2.3  Blood and Cultured Cell Handling 
The human T-cell line CRL-1942 (American Type Culture Collection, Rockville, 
MD) was cultured in RPMI 1640 media supplemented with 10% fetal calf serum, 
penicillin (100 µg/mL), and streptomycin (100 µg/mL) (Invitrogen Corp., Carlsbad, CA).  
Cells were washed with PBS two times by centrifugation at 1500 rpm, and dispersed in 
PBS buffer (pH=7.4) supplemented with fetal calf serum (BD Biosciences, San Jose, 
CA).  Whole human blood was extracted by fingerstick and immediately transferred to a 
tube containing EDTA (BD Medical, New Brunswick, NJ) to prevent blood coagulation.  
The blood was then diluted (1:10) in PBS buffer.  Quantum Dot 605 Anti-CD8 and 
Quantum Dot 655 Anti-CD4 antibodies (Invitrogen) (5 µL each) were then added to the 
diluted blood (to obtain a final sample volume of 200 µL) and mixed for 30 minutes in 
the dark with continuous mixing.  
 
5.2.4  Cytometry Comparison Experiments 
To evaluate the accuracy of microfluidic based immunophenotyping, results were 
compared to the Cyan ADP flow cytometry system (Beckman-Coulter, Fullerton, CA).  
Human blood—collected simultaneously with the blood analyzed using the microfluidic 
system—was labeled the same as described in the previous section.  Zapoglobin 
(Beckman Coulter, Brea, CA) lysis solution was then added to the labeled blood solutions 
and incubated for 5 minutes.  Solutions were then washed by centrifugation two times 
and dispersed in PBS buffer (500 µL) in polypropylene tubes for flow cytometric 
analysis. 
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5.3  Results  
5.3.1  Microchip Operation   
A 100-µL aliquot of the antibody labeled blood sample is introduced at the 
sample reservoir on the chip.  The blood sample is driven through the chip by applying a 
sub-ambient pressure using a syringe pump attached to the Waste 2 reservoir (Figure 
5.1a).  As the blood travels through the device, it approaches an intersecting orthogonal 
channel—labeled Lyse in Figure 5.1a—containing the commercially available lysis 
solution Zapoglobin. 
Figure 5.1b shows the intersecting fluid flow containing the Zapoglobin from the 
lyse channel and the blood sample from the main channel, with arrows indicating flow 
direction.  The Zapoglobin is continuously infused onto the device using a syringe pump 
at a flow rate of 1 µL/min.  The blood sample stream is hydrodynamically focused 
against the channel wall by the infused lysis solution (Fig. 1B).  This reduces the distance 
required for the Zapoglobin to diffuse into the blood sample stream, leading to increased 
erythrocyte lysis efficiency.  After an interaction time of approximately 2 seconds, the 
cell stream arrives at a second orthogonal channel (labeled Waste 1 in Figure 5.1a) as 
depicted in Figure 5.1c.  Fluid is withdrawn at this intersection (arrows in Figure 5.1c 
indicate flow direction) at a flow rate of 1 µL/min, equivalent to the flow rate of the 
infused lysis solution, using another syringe pump to remove unwanted lysis debris. 
Intact cells have a much lower diffusion coefficient than cell lysate debris and remain 
primarily within the cell sample stream.  Visual monitoring confirmed minimal intact cell 
losses through this side channel. 
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The remaining cells travel through one final intersection that is used for 
hydrodynamic focusing.  Buffer solution focuses the cell stream from both sides to ensure 
the cells are in single file at the detection point.  The cells pass through a focused laser 
beam used for light scatter and laser induced fluorescence based detection.  Figure 5.1d 
shows the fully assembled microchip with a piece of PDMS bonded to the top of the 
glass.  Cutouts for blood sample and sheath focusing buffer fluid reservoirs and via holes 
for tubing connections are integrated into the PDMS slab.  Another rectangular cutout in 
the PDMS slab provides a clear path for the incident laser beam to pass through the glass 
microchip, eliminating unnecessary optical effects caused by passing the beam through 
another material.   
 
5.3.2  Lysis Efficiency   
To assess the efficiency of selective erythrocyte lysis on-chip, the forward scatter 
signal obtained when a diluted blood sample was infused with lysis solution was 
compared to the result obtained using an isotonic (non-lysing) buffer solution.  Figure 
5.2a shows a representative segment of the forward scatter signal obtained when the 
blood sample was infused with buffer solution.  In this result, thousands of cells pass by 
the detection point every second as both erythrocytes and leukocytes are being detected.  
Figure 5.2b shows the forward scatter signal obtained when the blood sample is infused 
with lysis solution.  Significantly fewer forward scatter peaks can be seen as compared to 
runs where non-lysing buffer is infused.  A total of five 60 second acquisitions were 
obtained for both the lysis and buffer tests.  Compared with the non-lysing buffer 
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experiment, 86 ± 7 % fewer cells were detected when the lysis solution was infused with 
the blood sample.  Considering the large initial ratio of erythrocytes to leukocytes in the 
diluted blood sample, the magnitude of cell depletion shown here indicates that a 
majority of erythrocytes are lysed.  The depletion percentage could be increased by 
infusing a more potent lysis solution on-chip; however, a balance must be achieved 
between removing a significant fraction of erythrocytes to reduce the possibility of 
interference, and ensuring the viability of leukocytes for downstream analysis.     
 
5.3.3  Lysis Selectivity 
To demonstrate that on-chip lysis selectivity is maintained, a solution of cultured 
T-lymphocytes was analyzed to ensure that no significant leukocyte depletion occurrs.  
The same protocol as described in the lysis efficiency experiments was used.  A 
representative signal from the result obtained by infusing non-lysing buffer with a 
solution of cultured T-lymphocytes is shown in Figure 5.3a.  The concentration of cells 
detected on-chip is unchanged from the initial cell solution concentration.  A subset of 
the result from analyzing the T-lymphocytes infused with lysis solution is shown in 
Figure 5.3b.  Compared to the non-lysing buffer, infusion of lysis solution resulted in T-
lymphocyte losses of 6 ± 2%.  This result indicates the preservation of lysis selectivity 
on-chip and confirms that the protocol and solution concentrations chosen lyse 
erythrocytes with minimal leukocyte losses.   
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5.3.4  Immunophenotyping Erythrocyte Depleted Blood Samples   
Human blood extracted by a finger stick was used for immunophenotypic 
detection of lymphocytes on-chip.  CD4:CD8 ratios were measured from these blood 
samples and compared to results obtained using the commercially available Cyan flow 
cytometry system.  Diluted whole human blood with quantum dot labeled antibodies 
specific for CD4+ and CD8+ T-lymphocytes was added to the sample reservoir, and 
subjected to on-chip lysis to selectively deplete the concentration of unwanted 
erythrocytes.  Although complete erythrocyte depletion is not expected, a substantial 
reduction in erythrocyte numbers is adequate to facilitate the detection of target 
leukocytes without significant interference.  Fluorescence from the two types of quantum 
dots was measured as the erythrocyte depleted solution passed by the laser interrogation 
point after hydrodynamic focusing. 
Shown in Figure 5.4a is a subset from the raw PMT data for the two fluorescence 
channels.  The QD605 Anti-CD8 fluorescence signal is shown in black and the QD655 
Anti-CD4 fluorescence signal is shown in gray (offset for easier visualization).  This data 
was processed by extracting peak intensities for each detected event and plotted in a two-
dimensional scatter plot shown in Figure 5.4b.  A clear distinction between the two cell 
types is shown, demonstrating that the microfluidic device is capable of discriminating 
CD4+ and CD8+ T-lymphocytes in less than 30 minutes (including antibody labeling), 
which is clinically relevant for monitoring HIV and other immune disorders.  A minimum 
of 5 samples from the same donor sample were analyzed both on-chip and using the Cyan 
flow cytometer.  The CD4:CD8 ratio measured on the microfluidic device was 2.0 ± 0.4.  
In comparison, the CD4:CD8 ratio measured from the same blood donor using the Cyan 
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flow cytometer was 2.2 ± 0.2, demonstrating that the automated microfluidic lysis and 
cytometry instrument can accurately measure cell ratios comparable to those obtained 
using standard flow cytometry instrumentation.  
 
5.4  Conclusions  
The characterization of an automated microfluidic system incorporating selective 
erythrocyte lysis with flow cytometry for biomedical monitoring and diagnostic 
applications was described in this chapter.  Incorporating erythrocyte lysis on-chip 
reduces the number of manual sample processing steps required for sample analysis, 
providing an automated platform for erythrocyte lysis from clinical samples.  The device 
described is a modification of the device first described in Chapter 2, having the 
erythrocyte lysis component added to the front end of the chip.  This advancement 
provides a step towards the development of an automated “sample-in, answer-out” 
platform for blood leukocyte analysis.   
Lysis efficiency experiments were performed to ensure that a significant number 
of erythrocytes were removed from the blood sample, leaving a solution of enriched 
leukocytes for flow cytometry analysis.  Forward scatter signal was monitored as a blood 
sample was processed through the microfluidic device when Zapoglobin or non-lysing 
buffer was introduced into the Lysis input.  Results show that when Zapoglobin is 
introduced, more than 85% of cells were lysed compared to the concentration of cells 
observed with the non-lysing buffer.  However, not all erythrocytes were removed from 
the sample.  This is acceptable because the purpose of erythrocyte removal is to reduce 
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the potential for interference from the red blood cells during leukocyte detection.  As the 
erythrocyte to leukocyte ratio is reduced by selective cell lysis, the likelihood of 
interference is lessened.   
Further testing of the integrated device was done to ensure that the selectivity of 
the lysis solution was maintained during the on-chip lysis and cytometry assay.  Cultured 
T-lymphocytes were drawn through the device when Zapoglobin or non-lysing buffer 
was introduced into the Lysis input.  The forward scatter signal was compared for the two 
experiments and revealed minimal losses of the T-cells on-chip. It was determined that 
approximately 6% of the white blood cells are lost due to the interaction with the lysis 
solution. This demonstrates that the lysis solution selectively depletes erythrocytes 
without significantly altering the concentration of leukocytes of interest contained in the 
blood sample on-chip.  
 Immunophenotyping results for T-lymphocyte ratio measurements from a human 
blood sample after automated erythrocyte lysis on-chip show clear agreement with results 
obtained using standard manual erythorocyte lysis procedures followed by commercial 
flow cytometry analysis.  This result reveals the potential application of the integrated 
device for cell immunophenotyping of clinical samples for applications monitoring HIV 
progression, leukocyte malignancies, and other disorders.  Further, this result establishes 
a foundation for the use of this instrument for automated leukocyte characterization from 
whole blood.  
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5.5  Figures 
 
 
 
Figure 5.1  (A) Glass microfluidic chip used for integrated erythrocyte lysis and flow 
cytometry.  (B)  Image of blood and lysis solution intersection.  (C)  Image of lysis debris 
removal via side channel (Waste 1) and intact cells continuing downstream.  (D)  
Photograph of functional microfluidic device with a PDMS slab bonded on top of the 
glass to make tubing connections and fluid reservoirs for blood and sheath focusing 
buffer.   
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Figure 5.2  Representative signal from lysis efficiency experiments measuring forward 
scatter detection of diluted whole human blood (A) after on-chip infusion with non-lysing 
PBS buffer and (B) after on-chip infusion with Zapoglobin lysis buffer.   
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Figure 5.3  Representative signal from experiments employing CRL-1942 T-
lymphocytes detected on-chip for lysis selectivity studies after (A) infusion with PBS 
(non-lysing) buffer and (B) infusion with Zapoglobin lysis buffer. 
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Figure 5.4  (A) Subset of raw PMT data showing CD8 fluorescence signal in black and 
CD4 fluorescence signal (offset by 1000) in gray.  (B) Scatter plot for on-chip detection 
of CD4+ and CD8+ T-lymphocytes from erythrocyte depleted whole human blood.   
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CHAPTER 6:  
MONITORING LEUKOCYTE DEPLETION ON-CHIP – MOUSE BLOOD 
DOSIMETRY 
 
6.1  Introduction  
 Leukocytes are depleted from blood when exposed to ionizing radiation or 
chemotherapeutic drugs.  This effect is known as leucopenia, and is a result of 
irreversible cell damage caused by the induced radiation or drug interaction.  Exposed 
blood mononuclear cells are depleted by apoptosis or necrosis, and severely damaged or 
dead cells are cleared from the blood by phagocytosis.1  This causes a reduced number of 
circulating blood mononuclear cells in the affected host, which can lead to increased 
susceptibility to opportunistic infections, and can be fatal in severe cases.   
Monitoring the extent of damaging effects caused by ionizing radiation or drug 
interactions is known as dosimetry, and significant efforts have been made to develop 
accurate, reliable dosimetry assays for a large range of exposures.  Dosimetry assays are 
normally performed by monitoring the concentration of apoptotic cells in blood.1-8  
Examples of tests developed to detect apoptosis include fluorescence analysis of DNA 
unwinding (FADU) 2 and the terminal deoxynucleotidyl transferase (TDT) assay.2,9  
Additionally, numerous studies have been performed to establish the most suitable cell 
 
 
types to monitor for these measurements.  Findings from these studies have shown that 
leukocytes such as CD4+ and CD8+ T-lymphocytes and CD27+ B-lymphocytes are of 
particular importance due to the increased sensitivity of these cell types to ionizing 
radiation or chemotherapeutic drug interaction.7,8,10,11 
Other assays performed for dosimetry applications monitor DNA damage in the 
form of chromosomal aberrations.2,12,13  The frequency of observed aberrations is used to 
determine dose.  Some other assays developed for dosimetry are based on monitoring 
micronucleus formation14-18 or  detecting chromosomal translocations using fluorescence 
in situ hybridization (FISH).19,20  Though all these methods have proven to be accurate 
and effective for dosimetry applications, they are time consuming and require skilled 
technicians to execute.  As such, the development of a simple, inexpensive, and rapid 
dosimetry assay would be valuable.  
An important application for dosimeters is for monitoring the efficacy of drug and 
radiation therapies and determining proper chemotherapeutic and radiation dosing in 
cancer patients.  Studies have also suggested dosimetry measurements may be 
particularly useful for the prediction of clinical response to cancer therapies.7  Dosimetry 
also has important applications in the areas of rapid evaluation of radiation exposure from 
industrial accidents or in homeland security applications.   
The experiments described in this chapter use the microfluidic flow cytometry 
system to measure the depletion effects of different blood leukocyte subsets due to 
ionizing radiation or chemotherapeutic drug injection.  The microfluidic system may 
prove particularly advantageous for dosimetry applications since it can rapidly phenotype 
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leukocytes from the volume equivalent to a finger-stick of blood.  A similar approach 
was previously described by Chambers et al, where they monitored the dose dependent 
depletion of human peripheral blood mononuclear (PBM) cells by conventional flow 
cytometry.10  This application demonstrated cell depletion measurements from blood, but 
required large blood volumes for analysis using conventional flow cytometry.  A 
previously described protocol for phenotypic analysis of mouse peripheral blood 
leukocytes was employed for the assay described here, reducing processing requirements 
to immunophenotypically characterize cells from blood by applying a “no-lyse, no-wash” 
sample preparation protocol.21   
Mouse models were used for experimental testing of the microfluidic dosimetry 
system.  Animals were tested before and at regular intervals after exposure to total body 
irradiation (TBI) or chemotherapeutic drugs to demonstrate the use of the microfluidic 
system to monitor changes in specific blood leukocyte levels due to induced leucopenia.  
Cell depletion results were compared to results obtained using conventional flow 
cytometry, and specific assays were demonstrated using the microfluidic device as a 
proof of concept to reveal distinct advantages to performing these assays on-chip. 
 
6.2  Experimental 
6.2.1  Detection Configuration 
A simplified detection configuration used for the experiments described in this 
chapter is shown in Figure 6.1.  Experiments described utilize a single fluorescence 
channel for immunophenotyping applications without elastic scatter based detection.  The 
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optics are the same as described in Chapter 3 with the exception of the fewer detection 
channels. 
 
6.2.2  Animal Experiments 
All animal experiments were performed in accordance with the UNC Institutional 
Animal Care and Use Committee requirements.  Peripheral blood was collected by tail 
vein nick from adult C57Bl/6 mice (Jackson Labs, Bar Harbor, MA).  Doxorubicin HCl 
(Bedford Laboratories) was administered by intraperitoneal injection in a 2 mg/mL 
solution.  Animals were irradiated using a 137Cs AECL GammaCell 40 Irradiator (Atomic 
Energy of Canada), or using a XRAD320 (Precision XRay Inc.) biological irradiator with 
exposures performed at 320 kV, 12.5 mA.  Animals were placed 70 cm from the Cs or x-
ray source where they received an average dose rate of 0.53 Gy/min. 
 
6.2.3  Blood Sample Preparation 
 Blood samples obtained from tail nicks were collected into EDTA lined tubes 
(Vacutainer; BD Medical) and diluted by a factor of 10 with a solution of PBS stain 
buffer (BD Biosciences) to a final volume of 200-µL.  Fluorescently labeled antibodies 
(5-µL) for CD3 or CD11b were incubated and mixed with the blood samples for 30 
minutes. Labeled blood solutions were then directly analyzed without any erythrocyte 
lysis or washing steps.21 
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6.2.4  Cytometry Comparison Experiments 
To evaluate the accuracy of microfluidic dosimetry measurements, results were 
compared to the Cyan ADP flow cytometry system (Beckman-Coulter).  Mouse blood 
(100-µL)—collected simultaneously with the blood analyzed using the microfluidic 
system—was prepared in the same manner as the samples tested with the microfluidic 
system.  Measured cell concentrations were obtained from the Cyan using CountBright 
Absolute Counting Beads (Invitrogen). 
 
6.3  Results  
6.3.1  Comparison to Conventional Flow Cytometry 
 To assess whether the microfluidic flow cytometry system could accurately 
monitor leukocyte depletion for dosimetry applications, experiments were run in parallel 
with the Cyan flow cytometry system.  The experimental protocol involved measuring 
the CD3+ T-lymphocyte counts from the blood of 5 healthy animals using both systems.  
All animals were then simultaneously exposed to 7.5 Gy of Cesium radiation, and 
allowed to rest for 3 days.  Blood samples from each animal were then obtained 72 hours 
after irradiation and again analyzed using both systems.   
The result for this comparison study is shown in Figure 6.2.  The percent 
depletion measured for each individual animal using the microfluidic system is similar to 
the values obtained by conventional cytometry.  The average percent depletion from the 
microfluidic system for the 5 animals is 87.7%.  In comparison, the average percent 
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depletion measured using the Cyan system is 87.1%.  A two-tailed T-test reveals that 
these results are statistically equivalent (p > 0.05, 95% confidence limit).  It is important 
to note that the volumetric requirements for the commercial system are significantly 
higher than that of the microfluidic system.  Equivalent results were obtained in this 
study with less than 20-µL of blood for microfluidic analysis as compared to 100-µL 
required for the commercial system.  
 
6.3.2  Radiation Dosimetry 
 The microfluidic cytometer was used to monitor leukocyte depletion due to 
radiation exposure over the course of 5 weeks.  These experiments demonstrate the 
advantages associated with performing dosimetry measurements using the microfluidic 
system (low blood volume requirement, rapid analysis time, and low-cost) for 
applications in dose assessment for cancer treatment and patient evaluation in radiation 
exposure incidents.  Evaluation of lymphocytes after irradiation has been shown 
previously,4-8,11,12,19 and results from these studies have demonstrated a positive 
correlation between the extent of lymphocyte damage and dose. 
 The microfluidic cytometry system was used to monitor changes in the 
concentration of CD3+ T-lymphocytes from 16 mice.  The animals were separated into 4 
groups, and 3 of those groups were exposed to increasing amounts of x-ray irradiation.  
One group of animals was not irradiated, and served as a control.  The irradiated groups 
received x-ray doses ranging from 2.5 Gy up to a lethal 10 Gy.  Animals were then bled 
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every 7 days for 5 weeks to monitor radiation induced lymphocyte depletion at different 
doses using the microfluidic system.   
Figure 6.3 shows the result for the 5 week, 16 animal radiation dosimetry 
experiments.  Each trace represents the average CD3+ T-lymphocyte depletion percent 
measured for each group.  A minimum of 2000 events was measured from each sample, 
with data acquisition taking less than 10 minutes per sample.  The blue trace represents 
the average change in CD3+ percent for the non-irradiated control group.  This group did 
not show any significant depletion, as expected.  Further, a small increase was observed 
over the duration of the experiment, which is within the observed standard measurement 
error.  This small increase may be simply due to measurement variability, but it has also 
been considered that the increase may be due to either the method of tail bleeding or a 
stress response from the animals due to increased handling and bleeding.  The green and 
red traces represent the average depletion percentages observed for the groups receiving 
2.5 and 5 Gy doses, respectively.  For both traces, a nadir is reached approximately 7 
days post-irradiation, followed by a gradual recovery of cell counts.  The 5 Gy dose 
caused a larger depletion response than the 2.5 Gy dose, and recovery of cell counts from 
the 5 Gy dose group is much slower than the lower irradiated dose.  The black trace 
represents the group of animals irradiated with the highest x-ray dose (10 Gy).  This dose 
was projected to be lethal, and after 7 days, all animals in the group were euthanized due 
to their exceedingly poor health.  Measurements were made from the blood of the 
animals prior to being euthanized, and the results reveal that the CD3+ T-lymphocyte 
counts in these animals had been reduced to near zero.  This result is consistent with 
previous studies describing increased cell necrosis at high radiation levels.5,10 
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6.3.3  Serial Murine Dosimetry Measurements  
 In addition to demonstrating the use of the microfluidic cytometer for human 
dosimetry applications, the system was tested to establish the potential application for 
serial murine dosimetry measurements.  One important application for mouse dosimetry 
measurements is testing the efficacy of protective drugs that may be developed to reduce 
unwanted leucopenic effects after radiation or chemotherapy treatment.  These 
experiments can also give valuable information regarding initial depletion kinetics due to 
induced radiation or chemotherapeutic injection.   
The microfluidic system is uniquely capable of performing these measurements 
due to the low blood volume required for analysis.  An average sized mouse (20 grams) 
contains only about 2 mL of blood.  Conventional flow cytometry normally requires 
several hundred microliters of blood for analysis, which can only be obtained through a 
lethal cardiac puncture.  In contrast, we have demonstrated the ability to accurately 
monitor cell depletion from blood volumes under 20-µL.  If serial bleeds are to be 
performed, there are limitations to the amount of blood that may be removed and the 
frequency of bleeding to maintain animal health.  Performing serial bleeds instead of 
lethal cardiac punctures can provide more accurate results since using different animals at 
each time point can contribute added experimental variability.  Further, serial bleeds 
significantly reduce the number of animals required for these assays.  It would therefore 
be beneficial to have a platform capable of providing accurate dosimetry measurements 
from small volumes of mouse blood to facilitate serial measurements from each animal 
over short time periods. 
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 The microfluidic dosimetry measurements were performed as described earlier, 
except serial bleeds were done over the course of 12 hours.  Figure 6.4 shows the result 
from the analysis of average CD3+ cell depletion from 3 control animals receiving no 
radiation dose, and 3 animals receiving a lethal 10 Gy dose of TBI.  Serial bleeds were 
performed on each animal (including controls) before irradiation, and 1, 4, 8 and 12 hours 
post-irradiation.  The result shows a clear distinction between the irradiated and non-
irradiated control group, demonstrating the significant leucopenic effects of ionizing 
radiation immediately after TBI.  The control group showed no cell depletion, but did 
have an increase in measured CD3+ cell counts similar to the control group result 
observed in Figure 6.3.   
 
6.3.4  Doxorubicin Dosimetry 
 Cell depletion was also monitored using the microfluidic device for applications 
relating to chemotherapy induced leucopenia from peripheral blood.  The absence of 
selectivity exhibited by many chemotherapeutic drugs causes a significant depletion of 
PBM cells, in addition to the intended target tumor cells.22  Studies have shown that the 
chemotherapeutic drug Doxorubicin causes apoptosis in PBM cells within 24 hours of 
injection.23  It is therefore vital for clinicians to carefully monitor the damaging effects 
these non-discriminating pharmaceuticals have on cancer patients to ensure proper 
dosage.  This is especially critical for patients receiving multiple rounds of chemotherapy 
since their leukocyte levels may already be depleted from previous treatment. 
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Experiments developed to test the microfluidic device for measuring depletion 
due to drug injection monitored the number CD11b+ cells in mouse peripheral blood.  
The CD11b antigen is expressed  on monocytes, neutrophils and granulocytes, and it has 
been previously demonstrated that the chemotherapeutic drug Doxorubicin induces 
apoptosis in PBM cells expressing this antigen.23  We have chosen to monitor the 
deleterious effects of Doxorubicin on PBM cells expressing the CD11b antigen to 
demonstrate the use of the microfluidic system for rapid clinical blood testing to monitor 
therapeutic efficacy and for proper dose determination. 
     Figure 6.5 shows the result for the experiment monitoring CD11b+ leukocyte 
depletion from mouse peripheral blood.  This experiment tested the blood from a total of 
16 animals, split into 4 groups.  Blood samples were extracted from each animal and 
analyzed prior to, and every 7 days after Doxorubicin injection for 3 weeks.  A minimum 
of 2000 events was measured from each sample, with acquisition times under 10 minutes 
per sample.  Three groups of animals were given successively larger doses of 
Doxorubicin, while one control group of animals had no drug administered.  The average 
cell depletion result for the control group is shown in the black trace, while the average 
depletion result for the groups administered Doxorubicin are shown in green, red, and 
blue, representing doses of 5, 10, and 18 mg/ kg.  While there was no significant change 
in the average depletion measured for the control group over the 3 week experiment, all 3 
groups administered Doxorubicin showed measurable depletion depending on dose.  The 
depletion for each of those groups reached a nadir around the 7 day measurement, 
followed by a recovery in the CD11b+ cell counts.  There is a significant difference in the 
overall maximum depletion observed based on initial Doxorubicin dose.  Further, the 
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CD11b+ cell counts in animals receiving the larger doses take longer to recover.  Cell 
counts in the 5 and 10 mg/ kg group reach pre-dose levels after 21 days, while the cell 
counts remain significantly depleted at 21 days for the 18 mg/ kg dose group.   
Results from this assay could be particularly useful in the selection of subsequent 
chemotherapy doses.  For example, if a second dose were to be administered to each 
group after 21 days, the 18 mg/ kg group would likely be most susceptible to 
opportunistic infection or death caused by additional leucopenia since peripheral blood 
CD11b+ levels would already be reduced by half.  Performing these tests in clinics could 
substantially reduce the time patients wait for blood work—required for proper dosage 
determination—which can currently take hours.      
 
6.4  Conclusions  
The experiments detailed in this chapter were intended to demonstrate the use of 
the microfluidic cytometry system for blood based dosimetry applications.  The 
microfluidic system can perform dosimetry assays using less than 20-µL of whole blood, 
which is considerably less than required for conventional cytometry assays.  This is 
particularly advantageous when performing dosimetry measurements on mouse models 
because of their limited available volume of blood.  A “no-lyse, no-wash” protocol was 
employed for blood sample preparation to minimize sample processing steps and time 
required between blood extraction and analysis.  Results obtained using the microfluidic 
system for the depletion of CD3+ T-lymphocytes were compared to the Cyan system to 
demonstrate the accuracy of dosimetry measurements performed on-chip.  The results 
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clearly demonstrate that the results obtained from the low-volume assay performed using 
the microfluidic system are comparable to conventional cytometry results, establishing 
the foundation for use of the microchip system for additional applications in blood 
dosimetry.   
The microfluidic cytometry system was tested for the ability to monitor the extent 
of leucopenia after radiation exposure.  Results from this experiment clearly show that 
the microfluidic system can be used to discriminate between different groups of animals 
given successively larger doses of radiation based on cell depletion measurements.  This 
result is particularly useful for applications in clinics where blood testing is required for 
each radiation therapy patient before more radiation can be administered.  Since 
leucopenic effects must be carefully monitored to determine proper radiation dosage, a 
rapid inexpensive platform for performing these assays could significantly reduce the 
time patients need to wait for results. 
Experiments similar to those described for monitoring radiation induced 
leucopenia were investigated to monitor cell depletion due to chemotherapeutic drug 
injection.  The results from these experiments demonstrate the capacity for the 
microfluidic system to determine the extent of cell depletion based on administered 
Doxorubicin dose.  This result supports our assessment that the microfluidic system could 
be used by clinicians to facilitate the rapid determination of proper doses for patients 
undergoing multiple rounds of treatment.   
Another area investigated using the microfluidic system is the analysis of mouse 
blood from serial bleeds. To extract a sufficient volume of mouse blood for conventional 
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cytometry analysis lethal bleeds are normally performed.  A platform that requires low 
sample volumes would enable serial bleed analyses that may provide more accurate 
results since the same animals are being monitored, eliminating the variability of using 
different animals for each measurement. 
The experimental result demonstrates the microfluidic systems’ capacity to 
perform multiple dosimetry measurements from low-volume tail bleeds over a 12 hour 
period, and clearly shows the rapid depletion effect caused by high doses of TBI.  These 
experiments may prove useful for the investigation of depletion kinetics for specific cell 
types, potentially providing important information regarding the sensitivity of specific 
cell subsets to chemotherapeutic agents or ionizing radiation.  The analysis of cell 
depletion from serial animal bleeds can also be used for applications relating to the 
development and testing of new drugs meant to inhibit unwanted leucopenic effects 
induced by radiation or chemotherapy treatments.  This method can rapidly carry out 
these applications while significantly reducing animal use requirements.   
The microfluidic cytometry system was tested for use in dosimetry applications 
for the determination of proper therapeutic dosage.  Mouse models were used to 
demonstrate the potential advantages of performing these assays on-chip, and in the 
process, specific advantages relating to performing dosimetry assays from serial low-
volume tail bleeds were revealed.  These proof of concept experiments all monitored 
deleterious effects on blood cells due to induced radiation or administered drug, but other 
applications for this platform exist.  One major application that could be easily performed 
with the same system would be monitoring increases in blood cell concentrations due to  
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infection or leukemia, for example. The same advantages detailed above would be 
relevant for performing such measurements on-chip. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
6.5  Figures 
 
Figure 6.1  Schematic of the optical detection configuration for dosimetry experiments using the microfluidic cytometry instrument 
for the detection of a single fluorescence channel.  
  
 
Figure 6.2  Comparison of Cs-radiation (7.5-Gy, total body irradiation) induced CD3+ T-
cell depletion results obtained using the microfluidic system and the Cyan cytometry 
system.  
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Figure 6.3  Monitoring the percent of CD3+ lymphocyte depletion from the blood of 4 
groups of mice receiving different doses of x-ray total body irradiation (n=4).   
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Figure 6.4  Monitoring the percent of CD3+ lymphocyte depletion from serial bleeds of 2 
groups of mice receiving different doses of x-ray total body radiation over the course of 
12 hours (n=3).   
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Figure 6.5  Monitoring the percent of CD11b+ cell depletion from the blood of 4 groups 
of mice receiving different doses of Doxorubicin (n=4).   
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CHAPTER 7: 
INVESTIGATION OF OTHER MICRO-FLOW CYTOMETRY APPLICATIONS 
AND FUTURE DIRECTIONS 
 
7.1  Introduction 
 Many applications exist for a portable, inexpensive flow cytometry system such 
as  the one described in this dissertation.  Another application that we have investigated is 
the enumeration of rare circulating tumor cells that can be detected in blood for clinical 
cancer diagnostic purposes.1,2  We have also demonstrated the detection of intracellular 
components using the microfluidic system. The ability to detect these entities, including 
nucleic acid content 3-6 and phosphorylated proteins7-11, on-chip greatly increases the 
number of possible applications for the device.  Other applications and possible future 
directions, including advancements in instrumental design and hardware, for this project 
are discussed in this chapter. The continued integration of other sample processing and 
analysis steps is also discussed as potential future modifications to the system.   
 
 
 
 
 
7.2  Experimental 
7.2.1  Cell Culture and Staining Protocols  
The human T-cell line CRL-1942 (American Type Culture Collection, Rockville, 
MD) was cultured in RPMI 1640 media supplemented with 10% fetal calf serum, 
penicillin (100 µg/mL), and streptomycin (100 µg/mL) (Invitrogen Corp., Carlsbad, CA).  
Cells were washed and centrifuged at 1500 rpm, twice, and redispersed in PBS buffer 
(pH=7.4) supplemented with fetal calf serum (BD Biosciences, San Jose, CA).  Cells 
were prepared for staining by washing ≈106 cells by centrifugation at 300x g three times 
and redispersing cells in 50 µL of PBS buffer.  Cells were then labeled with an 
intracellular fluorescent dye by incubating them with 2 µL Calcein-AM (1 µg/ mL) 
(Invitrogen Corp., Carlsbad, CA) for 30 minutes.  
 
7.2.2  Animal Protocols 
All animal experiments were performed in accordance with the UNC Institutional 
Animal Care and Use Committee regulations.  Peripheral blood was collected by tail vein 
nick from adult C57Bl/6 mice (Jackson Labs). Animals were irradiated using a 137Cs 
AECL GammaCell 40 Irradiator (Atomic Energy of Canada) with exposures performed 
at 320 kV, 12.5 mA.  Animals were placed 70 cm from the Cs source where they received 
an average dose rate of 0.53 Gy/min. 
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7.2.3  Blood Sample Preparation  
 Blood samples obtained from tail nicks were collected into EDTA lined tubes 
(Vacutainer; BD Medical) and diluted by a factor of 5 with a solution of PBS stain buffer 
(BD Biosciences) to a volume of 100-µL.  Antibodies for CD3 (PE-Texas Red 
conjugated, 5-µL) (Invitrogen) were incubated with the blood samples for 20 minutes 
with continuous mixing.  Blood solutions were then diluted 2x with Cytofix buffer (BD 
Biosciences) to fix and permeabilize the target cells.  Caspase-3 antibody conjugated to 
FITC (BD Biosciences) (5-µL) was then added and the solution was incubated and 
continuously mixed for 20 minutes.  Labeled blood solutions were then directly analyzed 
without erythrocyte lysis or washing steps.12 
 
7.3  Results     
7.3.1  Rare Cell Detection 
 Previous work described in Chapter 4 was performed to establish the  ability to 
accurately  detect a particular cell line in a mixture at a concentration of one part per 
thousand  Many applications can be addressed given this level of sensitivity but the 
enumeration of rare circulating tumor cells requires the ability to detect cells at much 
lower concentrations.  Circulating tumor cells may be found at concentrations ranging 
from tens to hundreds per mL of whole blood.1,2  As such, detecting a substantial number 
of these cells requires the analysis of large sample volumes.  Using positive pressure to 
drive fluid flow as described in Chapter 3, large sample volumes may be accommodated 
with the microfabricated device. 
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Positive pressure driven microfluidic cytometry was performed on manufactured 
solutions of cultured T-lymphocytes dispersed at known concentrations into PBS buffer.  
The cell and buffer solutions were loaded into syringes and driven through the 
microfluidic system at a sample flow rate of 100 µL/ min and a sheath flow rate of 250 
µL/ min.  Three solutions of different cell concentrations were processed through the 
device, and 5 ten minute acquisitions were performed for each solution.  Figure 7.1 
shows the result for these experiments where the average normalized detected 
concentration is plotted for each of the three different cell solutions tested.  These results 
show that the microfluidic system is capable of accurately detecting cells in solutions at 
each of the concentrations tested, including the lowest tested concentration of 50 cells per 
mL, with a standard error of ± 9%.   
Experiments described based on the detection of T-lymphocytes in buffer 
solutions are only the first step in demonstrating the applicability of this instrument for 
determining levels of rare circulating tumor cells in blood.  Further experiments may also 
be performed to demonstrate the application to rare cell detection by spiking known 
concentrations of fluorescently labeled cells into a whole blood solution.  This 
experiment will verify whether or not the rare target cells can be detected in a complex 
mixture of many other cell types at significantly higher concentrations.  Clinical blood 
samples from cancer patients may be also tested to confirm that this system can be used 
for rare cell applications. 
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7.3.2  Intracellular Protein Detection 
 The detection of intracellular components requires the ability to permeabilize the 
cell membrane in order to introduce fluorescently labeled antibodies inside the cell.  
Commercially available products are made to fix and permeabilize cells for this purpose, 
and many assays have been developed to detect intracellular components using 
conventional flow cytometry.3-11  To demonstrate the use of the microfluidic system for 
the detection of intracellular components, the cysteine protease caspase-3 was monitored 
in T-lymphocytes from mouse blood after animals were exposed to TBI.  Caspases are 
key effectors in apoptosis, and T-cells in animals exposed to TBI should show increasing 
levels of many caspases, including caspase-3 expression over time as the number of 
apoptotic cells increases.13,14 
 Two animals exposed to 10 Gy of TBI were bled before and at multiple times 
after irradiation to simultaneously monitor changes in CD3+ T-cell concentrations and 
percent caspase-3 expression in detected lymphocytes.  The result for this experiment is 
shown in Figure 7.2.  Bleeds were performed 3 hrs, 24 hrs, 48 hrs, 120 hrs, and 288 hrs 
post TBI.  As shown in earlier experiments in Chapter 6, the CD3+ cell concentrations are 
depleted after TBI.  Due to diminishing health, animal M319 was euthanized 9 days post-
TBI, and animal M317 was euthanized after a tail bleed 288 hrs post-TBI.  Starting at the 
24 hrs post-TBI time point, the percent of CD3+ T-lymphocytes with measureable 
caspase-3 expression was monitored using the microfluidic system.  The percent of 
measurable caspase-3 expression in detected CD3+ cells increased post-TBI as expected, 
and the percent of remaining CD3+ cells expressing caspase-3 was close to 100% for 
animal M317 at 288 hours post-TBI.  This result demonstrates the capability of the 
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microfluidic cytometry system to monitor changes in intracellular protease caspase-3 and 
potentially many other intracellular components, as results obtained were as expected 
based on previous conventional flow cytometry results.13,14 
 
7.4  Future Directions   
There are a variety of potential future directions for the microfluidic cytometry 
system, including advanced instrument development, further integration of sample 
preparation or analysis processes, and continued demonstration of clinical applications 
that would benefit from the advantages afforded by the microchip system.  All of these 
areas are equally important, and future work may require advancements within each of 
these areas to demonstrate added functionality to the scientific community.  Specific 
advancements relating to the applicability of the system for field work and point-of-care 
applications would be most valuable considering the shortage of available inexpensive 
diagnostic and monitoring devices in resource poor settings throughout the world.   
 To modify or improve upon the microfluidic cytometry system hardware, a few 
approaches may be taken, including advanced multiplexing capabilities, simplification 
for 3rd world applications, or parallel processing.  Advancing the multiplexing capacity of 
the microfluidic cytometer would require the addition of PMT’s and optical filters to 
obtain more fluorescence detection channels.  Additional lasers could also be 
incorporated to increase the number of detectable fluorescent molecules available for 
sample characterization.   The addition of more detection channels would significantly 
increase the number of potential clinical and research applications by providing more 
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information about cell samples, but this comes at an increased cost and larger footprint.  
It must also be noted that with the continued addition of fluorescence detection channels, 
the potential for spectral crossover increases.  This will require advancement in software 
to compensate for the fluorescence spillover.  In addition, efforts could be made to 
modify the current optical configuration to accommodate side-scatter measurements. 
 Another potential area for advancement would be to focus on instrument 
simplification and the use of inexpensive components to make the system more attractive 
for applications in resource limited settings.  One example of a modification that could be 
made is the use of high power LED light sources instead of lasers.  Using smaller optical 
components and a smaller vacuum source could also significantly reduce the size of the 
instrument.  Additionally, efforts could be made to incorporate components with low 
power requirements to accommodate the operation of the instrument using batteries, thus 
facilitating use for applications in resource poor settings.     
 For situations where the sample throughput of the microfluidic system is too low 
for practical application, parallel processing may be employed.  A specific application 
where this may be necessary is for the detection of circulating tumor cells present at very 
low concentrations in blood.  The current system has been used to analyze blood samples 
at a maximum throughput of 100-µL per minute.  When looking for cells present at 
concentrations at or lower than 10 per mL, the microchip as currently configured would 
take many hours to analyze the volume required to count enough positive events to have 
statistical significance.  Modifying the microfluidic device design and detection 
configuration to accommodate multiple simultaneous parallel cytometry measurements 
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could greatly increase the maximum achievable sample throughput, resulting in faster 
analysis times for large sample volumes.15 
 In addition to improvements based on hardware, further integration of sample 
processing or cell analysis steps could significantly improve the ease of use and number 
of potential applications for the microfluidic system.  The integration of sample 
processing steps as discussed in Chapter 5 could significantly reduce the number of 
manual sample processing steps required for cell analysis from complex mixtures, 
potentially reducing overall assay times and providing more reproducible sample 
processing conditions compared to manual sample preparations.  Another sample 
processing step that could be integrated on-chip is fluorescent labeling.16,17  The 
interaction time of cell and antibody solutions can be precisely controlled on-chip, and 
washing steps could be included if determined necessary.   
 
 The cytometry signals obtained from the current system configuration could be 
used for selective cell isolation, and this has been described on-chip previously.18-21  Cell 
sorting on-chip can be particularly useful when further testing on specific cell subsets 
isolated from a complex cell solution is necessary.  An on-chip assay has also been 
described for the analysis of cell lysate contents.22  Cytometry information could be used 
to selectively lyse target cells, followed by electrophoretic separation of lysate contents to 
identify specific analytes.  All of these examples could greatly increase the functionality 
of the microfluidic system while reducing the overall analysis efforts required as 
compared to conventional assays.   
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 The microfluidic system as currently configured, or with added improvements as 
described earlier could be tested to reveal numerous other potential clinical and research 
applications.  Areas of particular importance are applications in tuberculosis and malaria 
detection and monitoring.  These diseases affect millions of people worldwide—mostly 
in resource limited settings—and the application of the microfluidic system (with specific 
advancements in engineering and portability) could provide an inexpensive platform for 
testing in these areas.23   
All of the suggestions for improvements and advancements are proposed in 
consideration for the development a multifunctional platform for numerous clinical and 
research applications.  Successful commercialization of a device targeting a specific 
application will require optimization of operational parameters and instrumental features. 
I have presented here a short list of improvements that may serve as a starting point 
allowing for continued progress toward the development of a commercially viable 
microfluidic instrument. 
 
7.5  Conclusions 
 This dissertation described the development, initial characterization, and 
performance of a microfluidic-based flow cytometry system for biomedical monitoring 
and diagnostic applications.  Employing inexpensive microfluidic chips is advantageous 
for the analysis of potentially infectious samples as the entire device is disposable, 
thereby reducing the potential of cross-contamination and eliminating the need for 
instrument sterilization procedures.  In addition, a single syringe pump or other simple 
126 
 
vacuum source can by employed for successful operation of the device.  Hydrodynamic 
focusing properties of the microfluidic flow chamber were characterized to ensure proper 
cell focusing, and optical measurement precision was assessed and compared to 
conventional flow cytometry results. 
T-cell enumeration has been demonstrated to confirm the potential use of this 
system for immunophenotypic analysis from blood or bone marrow aspirates.  Further 
development let to the integration of erythrocyte lysis on-chip to reduce manual sample 
processing steps required for blood analysis.  To demonstrate the capacity of this 
integrated device to analyze T-cells from whole blood, results from the integrated 
erythrocyte lysis and cytometry device were again compared to results obtained using a 
standard lysis protocol followed by analysis by conventional flow cytometry.  Another 
application investigated for this microfluidic system was blood dosimetry.  Mouse 
models exposed to radiation or a chemotherapeutic drug were used as models to 
demonstrate the potential use of this system to monitor cell depletion effects.  These 
measurements may prove particularly useful in the areas of dose assessment by clinicians 
and for rapid assessment of radiation exposure.  Continued demonstrations of potential 
applications included the detection of low concentration cells for detecting rare 
circulating tumor cells, and for the detection of intracellular proteins.   
All of the work described in this dissertation is meant to provide evidence that a 
functional flow cytometer can be fabricated using microfluidic chips, and to establish a 
foundation for the use of this instrument for numerous clinical and research applications.  
Significant efforts may prove necessary to advance this prototype into a commercially 
viable instrument, however, the fundamental components assembled, characterized, and 
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applied to proof-of-concept applications described here provide a basis from which the 
process can be initiated.  To date, this instrument has been demonstrated to function—as 
currently configured—as well as conventional cytometry instrumentation for initial 
proof-of-concept experiments in a smaller, less-expensive form, and has been 
successfully tested for use as a multifunctional platform for the analysis of numerous 
medical disorders based on established flow cytometry-based assays.   
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7.6  Figures 
 
 
 
 
 
 
Figure 7.1  Detection of low concentration solutions of cells in buffer to simulate the 
application of the microfluidic cytometry system for counting rare circulating tumor cells.  
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Figure 7.2  Simultaneous monitoring of T-lymphocyte depletion and changes in intracellular caspase expression after exposure to 
TBI.    
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APPENDIX A:   
LABVIEW SOFTWARE FOR DATA ANALYSIS 
 
Programs were developed using LabVIEW to analyze raw data from PMT current 
outputs and extract important peak information for detected events.  Data acquired using 
a 16-bit data acquisition card (NI PCI-5122) and a modified Ramsey group data 
acquisition program was imported to the program named Josh Mach VIII, and a screen 
capture of the program is shown in Figure A.1.  This figure shows the peak extraction 
portion of the program where the top graph plots the raw PMT outputs from both 
channels, while the bottom two graphs plot single channel peak intensity histograms.   
This program was developed in order to detect peaks from two individual 
channels above user defined or calculated threshold values.  Threshold values were 
normally set at 5 times the signal to noise ratio.  The program extracts a peak intensity 
and time stamp from each detected event.  Histograms are plotted for each individual 
channel, and the timestamps for events are used to correlate signals in both channels to 
plot two-dimensional histograms.  The LabVIEW program also can export both the single 
channel and dual channel histograms as spreadsheet files to facilitate further data 
analysis.   
Standard operating parameters for this program were to run 30 second 
acquisitions with resulting data files having 2 channels of data.  Since the standard data 
acquisition program saves every data point, and files were acquired at rates of 50 – 100 
kHz, large data files resulted.  Attempting to analyze data sets longer than 30 seconds 
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resulted in LabVIEW crashing and large data files had to be split up before analyzing 
with the Josh Mach VIII program. 
The limitations in data acquisition and analysis with the PCI-6251 hardware and 
Josh Mach VIII software led to the acquisition of a 14-bit high-speed data acquisition 
card (NI PXI-5122).  This use of 2 of these cards facilitated use for extended 
experimental acquisitions of data in up to four separate channels at acquisition rates up to 
10 MHz per channel.  A separate acquisition program was developed to use with these 
cards, and peak extraction was written into the acquisition program.  Using this program, 
only when the PMT output rises above a defined threshold value is data saved, and 
subsequently analyzed to extract a peak intensity and area for every detected event.  In 
this manner, this software could easily handle experimental acquisitions for many 
minutes. 
A screen capture of the front panel from the program titled “Peak Capture” is 
shown in Figure A.2.  The front panel shows the raw PMT data in the center graph and a 
two channel histogram on the right that are both updated in real-time.  The left side of the 
front panel are settings for which channels to acquire data from, data acquisition rate 
(usually 1 MHz per channel), and threshold levels.  This program allows for data to be 
saved, or thrown out at any time, and all data is saved to a spreadsheet file containing all 
important program settings and information about each individual event detected.   
For certain applications, it is desirable to extract information about a specific 
subset of data acquired, known as gating.  To do this analysis using LabVIEW, the 
program titled “Peak Analysis” was developed.  A screen capture of the front panel of 
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this program is shown in Figure A.3.  This program accepts spreadsheet files from the 
“Peak Capture” program as inputs, and displays the imported two channel histogram on 
the top left graph.  The cursor is used to draw a box around a specific population of cells 
or events of interest, and then pressing the update sub-array button displays only the 
selected region in the top right graph.  This action also extracts all of the peak data from 
only the selected region, and plots single channel histograms for peak intensity and peak 
area for each channel.  The data from the selected region can then be saved along with 
corresponding gating information.   
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Figure A.1  Screen capture of the front panel of the “Josh Mach VIII” program 
developed for the analysis of raw data acquired using the PCI-6251 data acquisition card. 
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Figure A.2  Screen capture of the front panel of the “Peak Capture” program developed 
for use with the PXI-5122 high-speed data acquisition cards. 
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Figure A.3  Screen capture of the front panel of the “Peak Analysis” program developed 
for analyzing gated subsets of data acquired using the PXI-5122 high-speed data 
acquisition cards and the “Peak Capture” program. 
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APPENDIX B:   
SIGNAL PROCESSING HARDWARE 
 
 
  Experiments requiring extended acquisition times at very high event rates have 
proven problematic for LabVIEW processing with current programs.  Although efforts 
were made to optimize the programs discussed in Appendix A, it was determined that 
another strategy for the extraction of peak information may be preferable.  With the 
assistance of the UNC Chemistry Electronics Facility, we developed and performed some 
initial tests on a hardware based peak detector and integrator.  The idea for this circuit is 
based on cytometry electronics from years ago. 
  The circuit developed is meant to work with LabVIEW, but can significantly 
reduce the software processing requirements since all of the peak extraction will be done 
using hardware.  The result is that only peak intensity and peak area values are sent to the 
software for each detected event.  The circuit is designed to work as follows; first, the 
raw PMT output from a detector channel (normally forward scatter) is compared to a 
defined threshold.  If the scatter signal is above the threshold, the peak detector and 
integrator circuits for each channel are initialized for a specific duration.  At the end of 
this “detection window,” a pulse is sent to the data acquisition card to alert the software 
to measure the peak intensities and areas from each card.  After this “sampling window” 
a pulse is send to each peak detector and integrator to reset them in order to sample the 
next event.   
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  A peak detecting and integrating circuit was developed and fabricated on a printed 
circuit board.  Three of these boards were built; one for the forward scatter signal, and 
two for fluorescence channels.  The circuit diagram for the peak detector and integrator is 
shown in Figure B.1.  The top half of the circuit is the peak detector, consisting of a half-
wave rectifier followed by an integrator.  This circuit charges a capacitor to a charge 
proportional to the intensity of the detected peak for that channel.  On the bottom of the 
circuit is the integrator, which charges another capacitor to a value proportional to the 
area of each detected peak.  A photograph of the assembled circuit is shown in Figure 
B.2. 
 A digital control circuit was also assembled in order to control the timing of the 
signal processing.  A schematic of the digital control circuit is shown in Figure B.3, and a 
photograph of this circuit is shown in Figure B.4.  This circuit utilizes a series of 
monostables and flip-flops to control the peak sampling duration, and also controls the 
initialization of the individual peak detector and integrator circuits based on the threshold 
value input.  Additionally, trigger pulses for software initialization and reset pulses are 
sent out from this circuit.   
 Photographs of the entire peak detector and integrator circuit are shown in Figures 
B.5 and B.6.  Initial testing was done using the assembled circuit by analyzing 
fluorescently labeled polystyrene beads on-chip, and monitoring the output from the peak 
detector and integrator using an oscilloscope.  A representative result from these tests is 
shown in Figure B.7.  The top trace shows the input peak signal obtained from the 
detection of a single fluorescent microbead.  The center trace shows the output signal 
from the peak detector circuit.  The amplitude of this peak is a measure of the detected 
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bead peak intensity, and a trigger pulse will be sent to the ADC to initialize sampling of 
the value of this peak in the last 50 µs of the pulse.  The bottom trace shows the output 
signal from the integrating circuit.  Similarly, the amplitude of this peak is a measure of 
the detected bead peak area, and the same trigger pulse is sent to the ADC to initialize 
sampling of the value of this peak in the last 50 µs of the pulse.  The peak detector and 
integrator signals simultaneously return to baseline after the ADC “sampling window” 
because each receive a reset pulse from the digital control circuit which discharges the 
capacitors in the circuits to prepare for the next event. 
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Figure B.1  Circuit diagram for the peak detector and integrator. 
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Figure B.2  Photograph of the peak detector and integrator circuit. 
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Figure B.3  Diagram for the digital circuit used to control timing of the peak detector and 
integrator. 
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Figure B.4  Photograph of the installed digital control circuit. 
 
 
 
 
 
 
 
 
 
 
 
145 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B.5  Photograph of the front panel of the assembled peak detector and integrator. 
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Figure B.6  Photograph of the interior of the assembled peak detector and integrator with 
all boards mounted and a power supply installed. 
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Figure B.7  Result from the initial testing of the peak detector and integrator circuits 
showing the detection of a single event in the top blue trace, and the peak detector and 
integrator output signals in the center red and bottom green traces, respectively. 
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